[go: up one dir, main page]

CN102105433B - 6-nitroacetophenone compound, its preparation method and use - Google Patents

6-nitroacetophenone compound, its preparation method and use Download PDF

Info

Publication number
CN102105433B
CN102105433B CN200980129186.8A CN200980129186A CN102105433B CN 102105433 B CN102105433 B CN 102105433B CN 200980129186 A CN200980129186 A CN 200980129186A CN 102105433 B CN102105433 B CN 102105433B
Authority
CN
China
Prior art keywords
compound
formula
reaction
cyano
ethyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
CN200980129186.8A
Other languages
Chinese (zh)
Other versions
CN102105433A (en
Inventor
茆勇军
李剑峰
谢凯
李海泓
张容霞
段宏亮
郭洪利
沈敬山
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Shanghai Institute of Materia Medica of CAS
Topharman Shanghai Co Ltd
Original Assignee
Shanghai Institute of Materia Medica of CAS
Topharman Shanghai Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Shanghai Institute of Materia Medica of CAS, Topharman Shanghai Co Ltd filed Critical Shanghai Institute of Materia Medica of CAS
Priority to CN200980129186.8A priority Critical patent/CN102105433B/en
Publication of CN102105433A publication Critical patent/CN102105433A/en
Application granted granted Critical
Publication of CN102105433B publication Critical patent/CN102105433B/en
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D215/00Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/16Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D215/20Oxygen atoms
    • C07D215/24Oxygen atoms attached in position 8
    • C07D215/26Alcohols; Ethers thereof
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C205/00Compounds containing nitro groups bound to a carbon skeleton
    • C07C205/27Compounds containing nitro groups bound to a carbon skeleton the carbon skeleton being further substituted by etherified hydroxy groups
    • C07C205/35Compounds containing nitro groups bound to a carbon skeleton the carbon skeleton being further substituted by etherified hydroxy groups having nitro groups and etherified hydroxy groups bound to carbon atoms of six-membered aromatic rings of the carbon skeleton
    • C07C205/36Compounds containing nitro groups bound to a carbon skeleton the carbon skeleton being further substituted by etherified hydroxy groups having nitro groups and etherified hydroxy groups bound to carbon atoms of six-membered aromatic rings of the carbon skeleton to carbon atoms of the same non-condensed six-membered aromatic ring or to carbon atoms of six-membered aromatic rings being part of the same condensed ring system
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C211/00Compounds containing amino groups bound to a carbon skeleton
    • C07C211/43Compounds containing amino groups bound to a carbon skeleton having amino groups bound to carbon atoms of six-membered aromatic rings of the carbon skeleton
    • C07C211/44Compounds containing amino groups bound to a carbon skeleton having amino groups bound to carbon atoms of six-membered aromatic rings of the carbon skeleton having amino groups bound to only one six-membered aromatic ring
    • C07C211/45Monoamines
    • C07C211/46Aniline
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C211/00Compounds containing amino groups bound to a carbon skeleton
    • C07C211/43Compounds containing amino groups bound to a carbon skeleton having amino groups bound to carbon atoms of six-membered aromatic rings of the carbon skeleton
    • C07C211/44Compounds containing amino groups bound to a carbon skeleton having amino groups bound to carbon atoms of six-membered aromatic rings of the carbon skeleton having amino groups bound to only one six-membered aromatic ring
    • C07C211/49Compounds containing amino groups bound to a carbon skeleton having amino groups bound to carbon atoms of six-membered aromatic rings of the carbon skeleton having amino groups bound to only one six-membered aromatic ring having at least two amino groups bound to the carbon skeleton
    • C07C211/50Compounds containing amino groups bound to a carbon skeleton having amino groups bound to carbon atoms of six-membered aromatic rings of the carbon skeleton having amino groups bound to only one six-membered aromatic ring having at least two amino groups bound to the carbon skeleton with at least two amino groups bound to carbon atoms of six-membered aromatic rings of the carbon skeleton
    • C07C211/51Phenylenediamines
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C215/00Compounds containing amino and hydroxy groups bound to the same carbon skeleton
    • C07C215/74Compounds containing amino and hydroxy groups bound to the same carbon skeleton having hydroxy groups and amino groups bound to carbon atoms of six-membered aromatic rings of the same carbon skeleton
    • C07C215/76Compounds containing amino and hydroxy groups bound to the same carbon skeleton having hydroxy groups and amino groups bound to carbon atoms of six-membered aromatic rings of the same carbon skeleton of the same non-condensed six-membered aromatic ring

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

本发明涉及式I所示的6-硝基苯乙酮类化合物及其制备方法,其中取代基如说明书中所定义,及其用于制备3-取代-4-羟基喹啉类化合物和3-取代-4-氯代喹啉类化合物的用途,及式I化合物的中间体。 The present invention relates to 6-nitroacetophenone compounds shown in formula I and preparation method thereof, wherein the substituents are as defined in the description, and used for the preparation of 3-substituted-4-hydroxyquinoline compounds and 3- Uses of substituted-4-chloroquinoline compounds, and intermediates of compounds of formula I.

Description

6-硝基苯乙酮类化合物、其制备方法及用途6-nitroacetophenone compound, its preparation method and use

技术领域 technical field

本发明涉及可用于制备3-取代-4-羟基喹啉类化合物和3-取代-4-氯代喹啉类化合物的6-硝基苯乙酮类化合物及其制备方法和用途,以及其中间体。更具体而言,涉及结构式如下文式I所示的6-硝基苯乙酮类化合物及其制备方法和其用于制备3-取代-4-羟基喹啉类化合物(式A所示化合物)和3-取代-4-氯代喹啉类化合物(式A’所示化合物)的用途。The present invention relates to the 6-nitroacetophenone compound that can be used for preparing 3-substituted-4-hydroxyquinoline compound and 3-substituted-4-chloroquinoline compound and its preparation method and application, and its intermediate body. More specifically, it relates to a 6-nitroacetophenone compound whose structural formula is shown in the following formula I and its preparation method and its use in the preparation of 3-substituted-4-hydroxyquinoline compounds (compounds shown in formula A) and 3-substituted-4-chloroquinoline compounds (compounds shown in formula A').

背景技术 Background technique

3-取代-4-羟基喹啉类化合物(式A)以及3-取代-4-氯代喹啉类化合物(式A’)是重要的医药中间体,是制备3,4-二取代喹啉类化合物的重要中间体。例如,3,4-二取代喹啉类化合物是不可逆小分子酪氨酸激酶抑制剂(Journal of Medicinal Chemistry,46(1):49-63),具有抗癌活性,其中的部分化合物如EKB-569和HKI-272(Journal of Medicinal Chemistry,48(4):1107-1131)等对治疗大肠癌、乳腺癌和非小细胞肺癌有效,已经进入临床研究阶段,很有可能会成为具有较好市场前景的抗肿瘤新药。还有Bosutinib(SKI-606)(Journal of Medicinal Chemistry,2001,44(23),3965-3977),也是临床上很有希望的抗肿瘤新药。3-substituted-4-hydroxyquinoline compounds (formula A) and 3-substituted-4-chloroquinoline compounds (formula A') are important pharmaceutical intermediates and are used to prepare 3,4-disubstituted quinolines important intermediates of compounds. For example, 3,4-disubstituted quinoline compounds are irreversible small molecule tyrosine kinase inhibitors (Journal of Medicinal Chemistry, 46(1):49-63), which have anticancer activity, and some compounds such as EKB- 569 and HKI-272 (Journal of Medicinal Chemistry, 48(4): 1107-1131) are effective in the treatment of colorectal cancer, breast cancer and non-small cell lung cancer. Promising new antitumor drugs. There is also Bosutinib (SKI-606) (Journal of Medicinal Chemistry, 2001, 44(23), 3965-3977), which is also a clinically promising new anti-tumor drug.

当式A中的X为酯基时,不同的3,4-二取代喹啉类化合物在抗疟、抗球虫病(US3542781)或治疗II型糖尿病(WO2005073229)方面也具有广泛应用。因此,优化3-取代-4-羟基喹啉类化合物和3-取代-4-氯代喹啉类化合物的合成工艺,就具有重要的实用价值。When X in formula A is an ester group, different 3,4-disubstituted quinoline compounds are also widely used in antimalarial, anti-coccidiosis (US3542781) or treatment of type II diabetes (WO2005073229). Therefore, optimizing the synthesis process of 3-substituted-4-hydroxyquinoline compounds and 3-substituted-4-chloroquinoline compounds has important practical value.

该类化合物的关键合成步骤在于喹啉母环的形成,而喹啉母环的合成多需用到高温条件。例如当X为氰基时,式A化合物的制备方法为,将式C化合物于高沸点溶剂中加热到240℃-260℃反应10-20小时(反应式I)(WO03093241,WO2005065181,CN101012225)。所用反应条件较为苛刻,且收率低,仅为40~50%,而且高沸点溶剂如道生油(Dowtherm)在高温下不可避免的挥发对工作环境与操作人员的健康有不利影响,对环境有污染,不适合用于大规模工业生产。因此,寻找条件温和、收率高、成本低、对环境污染小的、适于工业化生产的制备方法就变得尤为迫切。The key synthetic step of this kind of compound lies in the formation of quinoline mother ring, and the synthesis of quinoline mother ring usually requires high temperature conditions. For example, when X is a cyano group, the preparation method of the compound of formula A is to heat the compound of formula C in a high boiling point solvent to 240°C-260°C for 10-20 hours (reaction formula I) (WO03093241, WO2005065181, CN101012225). The reaction conditions used are relatively harsh, and the yield is low, only 40 to 50%, and the unavoidable volatilization of high boiling point solvents such as Dowtherm at high temperature has adverse effects on the working environment and the health of operators, and has a negative impact on the environment. Pollution, not suitable for large-scale industrial production. Therefore, it is particularly urgent to find a preparation method with mild conditions, high yield, low cost, little environmental pollution and suitable for industrial production.

反应式IReaction I

发明内容 Contents of the invention

本发明人致力于寻找条件温和、操作简便、收率高、成本低、安全环保、适合大规模商业化生产的3-取代-4-羟基喹啉类化合物和3-取代-4-氯代喹啉类化合物的制备方法。由此发明了结构式如下文式I所示的6-硝基苯乙酮类化合物,并采用式I所示的6-硝基苯乙酮类化合物简便、高收率地合成了3-取代-4-羟基喹啉类化合物和3-取代-4-氯代喹啉类化合物。The inventors are committed to finding 3-substituted-4-hydroxyquinoline compounds and 3-substituted-4-chloroquine with mild conditions, easy operation, high yield, low cost, safety and environmental protection, suitable for large-scale commercial production The preparation method of morphine compound. The 6-nitroacetophenone compound shown in the following formula I has thus been invented, and the 6-nitroacetophenone compound shown in formula I is used to synthesize 3-substituted- 4-hydroxyquinoline compounds and 3-substituted-4-chloroquinoline compounds.

本发明的一个目的是提供6-硝基苯乙酮类化合物。One object of the present invention is to provide 6-nitroacetophenones.

本发明的另一个目的是提供上述6-硝基苯乙酮类化合物的制备方法。Another object of the present invention is to provide a preparation method of the above-mentioned 6-nitroacetophenone compounds.

本发明的还一目的是提供上述6-硝基苯乙酮类化合物的用途。Another object of the present invention is to provide the use of the above-mentioned 6-nitroacetophenone compounds.

本发明的又一目的是提供上述制备方法涉及的中间体。Another object of the present invention is to provide intermediates involved in the above preparation method.

本发明提供如下式I所示的6-硝基苯乙酮类化合物:The present invention provides 6-nitroacetophenone compounds shown in the following formula I:

式I中,In formula I,

X为氰基、三氟甲基、硝基、-NHCOR3、-NHCOOR3、-CONR3R3’、-N=CHR3或-CO2R3,其中R3和R3’彼此相同或不同地为氢、C1~C10烷基、C1~C10链烯基、芳基或芳基取代的C1~C10烷基;X is cyano, trifluoromethyl, nitro, -NHCOR 3 , -NHCOOR 3 , -CONR 3 R 3 ', -N=CHR 3 or -CO 2 R 3 , wherein R 3 and R 3 'are identical to each other or Variously hydrogen, C1~C10 alkyl, C1~C10 alkenyl, aryl or C1~C10 alkyl substituted by aryl;

Z为-NH-、-O-或 Z is -NH-, -O- or

R1及R1’彼此相同或不同地为甲酰基、C1~C10烷基、C1~C10链烯基、芳基、芳基取代的C1~C10烷基、C1~C10烷酰基、芳酰基、芳基取代的C1~C10烷酰基、C1~C10烷氧基羰基或芳基取代的C1~C10烷氧基羰基;R 1 and R 1 ' are the same or different from each other as formyl, C1-C10 alkyl, C1-C10 alkenyl, aryl, aryl-substituted C1-C10 alkyl, C1-C10 alkanoyl, aroyl, Aryl substituted C1~C10 alkanoyl, C1~C10 alkoxycarbonyl or aryl substituted C1~C10 alkoxycarbonyl;

R2为C1~C10烷基、C1~C10链烯基或芳基,所述烷基不必须地被卤素、烷氧基、芳基或者含1~2个O或N的杂环基(例如吡咯烷基、哌啶基、吗啉基、哌嗪基、高哌嗪基)取代,其中所述杂环基不必须地被C1~C10烷基或C1~C10烷氧基取代;R 2 is C1~C10 alkyl, C1~C10 alkenyl or aryl, and said alkyl is not necessarily replaced by halogen, alkoxy, aryl or heterocyclic group containing 1~2 O or N (such as Pyrrolidinyl, piperidinyl, morpholinyl, piperazinyl, homopiperazinyl), wherein the heterocyclic group is not necessarily substituted by C1~C10 alkyl or C1~C10 alkoxy;

且当Z为-O-、R1为甲基时,R2不为甲基。And when Z is -O-, R 1 is methyl, R 2 is not methyl.

在本发明优选的实施方案中,式I中,In a preferred embodiment of the present invention, in formula I,

X为氰基、三氟甲基、-NHCOR3、-NHCOOR3、-N=CHR3、C1~C10烷氧羰基或羧基;X is cyano, trifluoromethyl, -NHCOR 3 , -NHCOOR 3 , -N=CHR 3 , C1~C10 alkoxycarbonyl or carboxyl;

Z为-NH-或-O-;Z is -NH- or -O-;

R1为C1~C5烷基、乙酰基、丙酰基、苯甲酰基、叔丁氧羰基、苄基、苄氧羰基或三苯甲基;R 1 is C1~C5 alkyl, acetyl, propionyl, benzoyl, tert-butoxycarbonyl, benzyl, benzyloxycarbonyl or trityl;

R2为甲基、乙基、丙基、苄基、-(CH2)n-Cl、-(CH2)n-Br、其中n=1~5的整数,Alkyl为C1~C5烷基。R 2 is methyl, ethyl, propyl, benzyl, -(CH 2 ) n -Cl, -(CH 2 ) n -Br, or Wherein n=1-5 integer, Alkyl is C1-C5 alkyl.

在本发明进一步优选的实施方案中,式I中,In a further preferred embodiment of the present invention, in formula I,

X为氰基(-CN)、乙氧羰基(-COOC2H5)、甲氧羰基(-COOCH3);X is cyano (-CN), ethoxycarbonyl (-COOC 2 H 5 ), methoxycarbonyl (-COOCH 3 );

Z为-NH-或-O-;Z is -NH- or -O-;

R1为乙酰基、苯甲酰基、苄基或甲基; R is acetyl, benzoyl, benzyl or methyl;

R2为乙基、-(CH2)3-Cl、-(CH2)3-Br、 R 2 is ethyl, -(CH 2 ) 3 -Cl, -(CH 2 ) 3 -Br, or

在本发明更进一步优选的实施方案中,式I为:In a further preferred embodiment of the present invention, formula I is:

3’-乙酰胺基-4’-乙氧基-6’-硝基-2-氰基苯乙酮;3'-acetamido-4'-ethoxy-6'-nitro-2-cyanoacetophenone;

3’-苯甲酰胺基-4’-乙氧基-6’-硝基-2-氰基苯乙酮;3'-benzamido-4'-ethoxy-6'-nitro-2-cyanoacetophenone;

3’-苄胺基-4’-乙氧基-6’-硝基-2-氰基苯乙酮;3'-Benzylamino-4'-ethoxy-6'-nitro-2-cyanoacetophenone;

3’-乙酰胺基-4’-乙氧基-6’-硝基-2-乙氧基羰基苯乙酮;3'-acetamido-4'-ethoxy-6'-nitro-2-ethoxycarbonylacetophenone;

3’-甲氧基-4’-(4-甲基-1-哌嗪基)丙氧基-6’-硝基-2-氰基苯乙酮。3'-methoxy-4'-(4-methyl-1-piperazinyl)propoxy-6'-nitro-2-cyanoacetophenone.

本发明涉及式I所示的6-硝基苯乙酮类化合物的制备方法,其特征在于,该方法包括:The present invention relates to the preparation method of the 6-nitroacetophenone compound shown in formula I, it is characterized in that, this method comprises:

(1)当X为氰基、三氟甲基、硝基、-NHCOR3、-NHCOOR3、-CONR3R3’、-N=CHR3或-CO2R3,其中R3和R3’彼此相同或不同地为氢、C1~C10烷基、C1~C10链烯基、芳基或芳基取代的C1~C10烷基时,由化合物V经脱羧反应得到化合物I;其反应式为:(1) When X is cyano, trifluoromethyl, nitro, -NHCOR 3 , -NHCOOR 3 , -CONR 3 R 3 ', -N=CHR 3 or -CO 2 R 3 , wherein R 3 and R 3 When 'the same or different are hydrogen, C1~C10 alkyl, C1~C10 alkenyl, aryl or C1~C10 alkyl substituted by aryl, compound I is obtained from compound V through decarboxylation; its reaction formula is :

其中,in,

Z为-NH-、-O-或 Z is -NH-, -O- or

R1及R1’彼此相同或不同地为甲酰基、C1~C10烷基、C1~C10链烯基、芳基、芳基取代的C1~C10烷基、C1~C10烷酰基、芳酰基、芳基取代的C1~C10烷酰基、C1~C10烷氧基羰基或芳基取代的C1~C10烷氧基羰基;R 1 and R 1 ' are the same or different from each other as formyl, C1-C10 alkyl, C1-C10 alkenyl, aryl, aryl-substituted C1-C10 alkyl, C1-C10 alkanoyl, aroyl, Aryl substituted C1~C10 alkanoyl, C1~C10 alkoxycarbonyl or aryl substituted C1~C10 alkoxycarbonyl;

R2为C1~C10烷基、C1~C10链烯基或芳基,所述烷基不必须地被卤素、烷氧基、芳基或者含1~2个O或N杂环基(例如吡咯烷基、哌啶基、吗啉基、哌嗪基、高哌嗪基)取代,其中所述杂环基不必须地被C1~C10烷基或C1~C10烷氧基取代;R 2 is C1~C10 alkyl, C1~C10 alkenyl or aryl, and said alkyl is not necessarily replaced by halogen, alkoxy, aryl or heterocyclic group containing 1~2 O or N (such as pyrrole Alkyl, piperidinyl, morpholinyl, piperazinyl, homopiperazinyl), wherein the heterocyclic group is not necessarily substituted by C1~C10 alkyl or C1~C10 alkoxy;

R4为氢、C1~C10烷基、C1~C10链烯基、芳基或芳基取代的C1~C10烷基; R4 is hydrogen, C1~C10 alkyl, C1~C10 alkenyl, aryl or C1~C10 alkyl substituted by aryl;

且当Z为-O-、R1为甲基时,R2不为甲基。And when Z is -O-, R 1 is methyl, R 2 is not methyl.

其中,化合物V可由市场购买;或以3,4-二取代-6-硝基苯甲酸为原料参照实施例十五或实施例二十三的方法制备得到。3,4-二取代-6-硝基苯甲酸可由市场购买或由3,4-二取代苯甲酸甲酯经硝化、水解酯基后制备得到,也可用3-氨基-4-取代-6-硝基苯甲酸经氨基化得到,或以3-取代-4-羟基-6-硝基-苯甲酸甲酯经醚化得到。Among them, compound V can be purchased from the market; or it can be prepared by referring to the method of Example 15 or Example 23 by using 3,4-disubstituted-6-nitrobenzoic acid as a raw material. 3,4-disubstituted-6-nitrobenzoic acid can be purchased from the market or prepared from 3,4-disubstituted methyl benzoate through nitration and hydrolysis of the ester group, and 3-amino-4-substituted-6- Nitrobenzoic acid can be obtained by amination or by etherification of 3-substituted-4-hydroxy-6-nitro-benzoic acid methyl ester.

或者or

(2)当X=氰基时,由化合物B硝化得到化合物D,化合物D溴代得到化合物II,化合物II经氰基取代反应得到化合物I;其反应式为:(2) When X=cyano group, compound D is obtained by nitration of compound B, compound D is brominated to obtain compound II, and compound II obtains compound I through cyano substitution reaction; its reaction formula is:

其中Z、R1和R2的定义同上;Wherein Z, R 1 and R 2 are as defined above;

或者or

(3)当X=氰基时,由化合物B溴化得到化合物III,化合物III硝化得到化合物II,化合物II经氰基取代反应得到化合物I;其反应式为:(3) When X=cyano group, compound III is obtained by bromination of compound B, compound III is nitrated to obtain compound II, and compound II obtains compound I through cyano substitution reaction; its reaction formula is:

其中Z、R1和R2的定义同上;Wherein Z, R 1 and R 2 are as defined above;

或者or

(4)当X=氰基时,由化合物B溴代得到化合物III,化合物III经氰基取代反应得到化合物IV,化合物IV硝化得到化合物I;其反应式为:(4) When X = cyano group, compound III is obtained by bromination of compound B, compound III is subjected to cyano substitution reaction to obtain compound IV, and compound IV is nitrated to obtain compound I; its reaction formula is:

其中Z、R1和R2的定义同上;Wherein Z, R 1 and R 2 are as defined above;

在上述反应中,式I化合物的制备中,所述脱羧、溴代、硝化、氰基取代等反应都是本技术领域内的常规反应。化合物B可由市场购买,或以对羟基苯乙酮为原料参照实施例一的方法合成,或者以3-甲氧基-4-羟基苯乙酮为原料参照实施例三十五的方法合成。In the above reactions, in the preparation of the compound of formula I, the decarboxylation, bromination, nitration, cyano substitution and other reactions are all conventional reactions in the technical field. Compound B can be purchased from the market, or synthesized by referring to the method of Example 1 using p-hydroxyacetophenone as a raw material, or using 3-methoxy-4-hydroxyacetophenone as a raw material by referring to the method of Example 35.

本发明还涉及式I所示的6-硝基苯乙酮类化合物的用途,其特征在于,The present invention also relates to the purposes of 6-nitroacetophenone compound shown in formula I, it is characterized in that,

式I所示的6-硝基苯乙酮类化合物可按如下方法制备式A所示化合物,The 6-nitroacetophenone compound shown in formula I can prepare the compound shown in formula A as follows,

其中,in,

X为氰基、三氟甲基、硝基、-NHCOR3、-NHCOOR3、-CONR3R3’、-N=CHR3、或CO2R3,其中R3和R3’彼此相同或不同地为氢、C1~C10烷基、C1~C10链烯基、芳基或芳基取代的C1~C10烷基;X is cyano, trifluoromethyl, nitro, -NHCOR 3 , -NHCOOR 3 , -CONR 3 R 3 ', -N=CHR 3 , or CO 2 R 3 , wherein R 3 and R 3 'are identical to each other or Variously hydrogen, C1~C10 alkyl, C1~C10 alkenyl, aryl or C1~C10 alkyl substituted by aryl;

Z为-NH-、-O-或 Z is -NH-, -O- or

R1及R1’彼此相同或不同地为甲酰基、C1~C10烷基、C1~C10链烯基、芳基、芳基取代的C1~C10烷基、C1~C10烷酰基、芳酰基、芳基取代的C1~C10烷酰基、C1~C10烷氧基羰基或芳基取代的C1~C10烷氧基羰基;R 1 and R 1 ' are the same or different from each other as formyl, C1-C10 alkyl, C1-C10 alkenyl, aryl, aryl-substituted C1-C10 alkyl, C1-C10 alkanoyl, aroyl, Aryl substituted C1~C10 alkanoyl, C1~C10 alkoxycarbonyl or aryl substituted C1~C10 alkoxycarbonyl;

R2为C1~C10烷基、C1~C10链烯基或芳基,所述烷基不必须地被卤素、烷氧基、芳基或者含1~2个O或N的杂环基取代,例如吡咯烷、哌啶、吗啉、哌嗪、高哌嗪,其中所述杂环可不必须地被C1~C10烷基或C1~C10烷氧基取代;R 2 is C1~C10 alkyl, C1~C10 alkenyl or aryl, and said alkyl is not necessarily substituted by halogen, alkoxy, aryl or heterocyclic group containing 1 to 2 O or N, For example, pyrrolidine, piperidine, morpholine, piperazine, homopiperazine, wherein the heterocycle may be optionally substituted by C1~C10 alkyl or C1~C10 alkoxy;

(1)化合物I与化合物E进行缩合反应得到式VI所示化合物,(1) compound I and compound E carry out condensation reaction to obtain the compound shown in formula VI,

其中,Y为-N(R5)2或-OR5,R5、R6和R7相同或不同地选自C1~C10烷基、C1~C10链烯基、芳基和芳基取代的C1~C10烷基中。Wherein, Y is -N(R 5 ) 2 or -OR 5 , R 5 , R 6 and R 7 are the same or different selected from C1~C10 alkyl, C1~C10 alkenyl, aryl and aryl substituted Among C1~C10 alkyl groups.

化合物VI在还原条件下得到式VII所示化合物,式VII所示化合物环合得到式A所示化合物;或者化合物VII可以不经分离直接进行环合反应得到式A所示化合物;其反应式为:Compound VI obtains the compound shown in formula VII under reducing conditions, and the compound shown in formula A is obtained by cyclization of the compound shown in formula VII; or compound VII can directly carry out cyclization reaction without separation to obtain the compound shown in formula A; its reaction formula is :

或者 or

(2)化合物I在还原条件下得到化合物VIII或化合物VIII的酸加成盐,化合物VIII(或其酸加成盐)与化合物E进行缩合反应得到化合物VII和/或化合物IX,化合物VII和/或化合物IX环合得到式A所示化合物;或者化合物VII和化合物IX可以不经分离直接进行环合反应得到式A所示化合物;其反应式为:(2) Compound I obtains compound VIII or an acid addition salt of compound VIII under reducing conditions, and compound VIII (or its acid addition salt) is condensed with compound E to obtain compound VII and/or compound IX, compound VII and/or Or compound IX cyclization obtains the compound shown in formula A; Or compound VII and compound IX can directly carry out cyclization reaction to obtain the compound shown in formula A without separation; Its reaction formula is:

or

;或者;or

(3)化合物I在还原条件下得到化合物VIII,化合物VIII的芳氨基与酸酐((R8)2O)或卤代物(例如R8Cl、R8Br)反应,得到化合物X,化合物X与化合物E进行缩合反应得到化合物XI,化合物XI经环合得到化合物XII,化合物XII脱R8保护基得到化合物A;其反应式为:(3) Compound I obtains Compound VIII under reducing conditions. The arylamino group of Compound VIII reacts with an acid anhydride ((R 8 ) 2 O) or a halide (such as R 8 Cl, R 8 Br) to obtain Compound X. Compound X and Compound E carries out condensation reaction and obtains compound XI, and compound XI obtains compound XII through cyclization, and compound XII removes R 8 protecting group obtains compound A; Its reaction formula is:

其中R8可以为一般的氨基保护基,即甲酰基、C1~C10烷酰基、芳酰基、芳基取代的C1~C10烷酰基、C1~C10烷氧基羰基或芳基取代的C1~C10烷氧基羰基。由化合物X制备化合物A的反应可以用一锅法完成,中间体XI和XII可以不经分离。Where R8 can be a general amino protecting group, namely formyl, C1~C10 alkanoyl, aroyl, aryl substituted C1~C10 alkanoyl, C1~C10 alkoxycarbonyl or aryl substituted C1~C10 alkane Oxycarbonyl. The reaction of preparing compound A from compound X can be accomplished in one pot, and intermediates XI and XII can be carried out without isolation.

上述制备化合物A的方法中,所述的与E进行缩合反应的条件可以是在不加催化剂的情况下直接将底物与E混合,在常温或加热条件下进行反应。所述的还原条件可以是:在氢化催化剂存在条件下,通入氢气进行反应,氢化催化剂可以为钯碳、活性镍或PtO2;也可以是:加入还原剂,例如加入铁粉、锌粉或氯化亚锡。由化合物VI制备化合物A可以是在还原剂存在的条件下还原和环合反应一步完成,无需分离中间体VII;由化合物VIII制备化合物A可以是将化合物VIII与E混合,在常温或加热条件下缩合和环合反应一步完成,无需分离中间体VII和/或IX。化合物X是由化合物VIII与含R8取代基的酸酐或卤代物进行常规的酰化或卤代反应得到。化合物E优选N,N-二甲酰胺二甲缩醛(DMF-DMA)、原甲酸三甲酯或原甲酸三乙酯。In the above method for preparing compound A, the conditions for the condensation reaction with E may be directly mixing the substrate with E without adding a catalyst, and then reacting at normal temperature or under heating conditions. Described reduction condition can be: in the presence condition of hydrogenation catalyst, pass into hydrogen to react, hydrogenation catalyst can be palladium carbon, active nickel or PtO 2 ; Also can be: add reducing agent, for example add iron powder, zinc powder or stannous chloride. Compound A can be prepared from compound VI by reducing and ring-closing in one step in the presence of a reducing agent, without the need to separate intermediate VII; by compound VIII, compound A can be prepared by mixing compound VIII and E, at normal temperature or under heating The condensation and cyclization reactions are accomplished in one step without isolation of intermediates VII and/or IX. Compound X is obtained by conventional acylation or halogenation reaction of compound VIII with acid anhydride or halide containing R 8 substituent. Compound E is preferably N,N-dimethylformamide dimethyl acetal (DMF-DMA), trimethyl orthoformate or triethyl orthoformate.

上述制备化合物A的方法中,优选的还原条件为:在氢化催化剂存在条件下,通入氢气进行反应,氢化催化剂为钯碳,所用溶剂为醋酸;或者还原条件为:加入还原剂,还原剂是铁粉或锌粉,进一步加入氯化钙或冰乙酸,所用溶剂为醇或醇-水混合溶剂。In the above-mentioned method for preparing compound A, the preferred reduction condition is: in the presence of a hydrogenation catalyst, feed hydrogen to react, the hydrogenation catalyst is palladium carbon, and the solvent used is acetic acid; or the reduction condition is: add a reducing agent, and the reducing agent is Iron powder or zinc powder, further adding calcium chloride or glacial acetic acid, the solvent used is alcohol or alcohol-water mixed solvent.

本发明还涉及式I所示的6-硝基苯乙酮类化合物的另一用途,其特征在于,式I所示的6-硝基苯乙酮类化合物可按如下方法制备式A’所示化合物,The present invention also relates to another use of the 6-nitroacetophenone compound shown in formula I, characterized in that the 6-nitroacetophenone compound shown in formula I can be prepared as follows: Show compounds,

其中,R1、R2、X和Z的定义同式A化合物。Wherein, the definitions of R 1 , R 2 , X and Z are the same as those of the compound of formula A.

(1)化合物I与化合物E进行缩合反应得到式VI所示化合物,(1) compound I and compound E carry out condensation reaction to obtain the compound shown in formula VI,

其中,Y为-N(R5)2或-OR5,R5、R6和R7相同或不同地选自C1~C10烷基、C1~C10链烯基、芳基和芳基取代的C1~C10烷基中。Wherein, Y is -N(R 5 ) 2 or -OR 5 , R 5 , R 6 and R 7 are the same or different selected from C1~C10 alkyl, C1~C10 alkenyl, aryl and aryl substituted Among C1~C10 alkyl groups.

化合物VI经还原、环合、氯代得到式A’化合物;或者其中中间体化合物VII、化合物A可不经分离直接反应得到式A’化合物;其反应式为:Compound VI is reduced, cyclized, and chlorinated to obtain a compound of formula A'; or wherein intermediate compound VII and compound A can be directly reacted without separation to obtain a compound of formula A'; its reaction formula is:

或者 or

(2)化合物I在还原条件下得到化合物VIII,化合物VIII与化合物E进行缩合反应得到化合物VII和/或化合物IX,化合物VII和/或化合物IX经环合、氯代得到式A’所示化合物;或者中间体化合物VII/化合物IX和化合物A不经分离直接制备式A’所示化合物;其反应式为:(2) Compound I obtains compound VIII under reducing conditions, compound VIII and compound E undergo condensation reaction to obtain compound VII and/or compound IX, compound VII and/or compound IX undergoes cyclization and chlorination to obtain the compound shown in formula A' or intermediate compound VII/compound IX and compound A directly prepare the compound shown in formula A' without separation; its reaction formula is:

or

上述制备化合物A’的方法中,所述还原、环合、与E进行缩合反应的条件同上述式A的制备方法。所述氯代反应可采用氯代试剂进行反应,例如采用三氯氧磷、五氯化磷等氯代试剂进行反应。In the above-mentioned method for preparing compound A', the conditions for the reduction, cyclization, and condensation reaction with E are the same as the preparation method of the above-mentioned formula A. The chlorination reaction can be carried out using a chlorinating reagent, for example, using a chlorinating reagent such as phosphorus oxychloride or phosphorus pentachloride.

本发明还提供下式II~XI的化合物:The present invention also provides compounds of the following formulas II to XI:

其中,X为氰基、三氟甲基、硝基、-NHCOR3、-NHCOOR3、-CONR3R3’、-N=CHR3或-CO2R3,其中R3和R3’彼此相同或不同地为氢、C1~C10烷基、C1~C10链烯基、芳基或芳基取代的C1~C10烷基;Z为-NH-、-O-或R1及R1’彼此相同或不同地为甲酰基、C1~C10烷基、C1~C10链烯基、芳基、芳基取代的C1~C10烷基、C1~C10烷酰基、芳酰基、芳基取代的C1~C10烷酰基、C1~C10烷氧基羰基或芳基取代的C1~C10烷氧基羰基;R2为C1~C10烷基、C1~C10链烯基或芳基,所述烷基不必须地被卤素、烷氧基、芳基或者含1~2个O或N的杂环基取代,例如吡咯烷基、哌啶基、吗啉基、哌嗪基、高哌嗪基,其中所述杂环基可不必须地被C1~C10烷基或C1~C10烷氧基取代;且当Z为-O-、R1为甲基时,R2不为甲基;Y为-N(R5)2或-OR5,R5选自C1~C10烷基、C1~C10链烯基、芳基和芳基取代的C1~C10烷基中;R8可以为一般的氨基保护基,即甲酰基、C1~C10烷酰基、芳酰基、芳基取代的C1~C10烷酰基、C1~C10烷氧基羰基或芳基取代的C1~C10烷氧基羰基。Wherein, X is cyano, trifluoromethyl, nitro, -NHCOR 3 , -NHCOOR 3 , -CONR 3 R 3 ', -N=CHR 3 or -CO 2 R 3 , wherein R 3 and R 3 ' are mutually The same or different hydrogen, C1~C10 alkyl, C1~C10 alkenyl, aryl or C1~C10 alkyl substituted by aryl; Z is -NH-, -O- or R 1 and R 1 ' are the same or different from each other as formyl, C1-C10 alkyl, C1-C10 alkenyl, aryl, aryl-substituted C1-C10 alkyl, C1-C10 alkanoyl, aroyl, Aryl substituted C1~C10 alkanoyl, C1~C10 alkoxycarbonyl or aryl substituted C1~C10 alkoxycarbonyl; R2 is C1~C10 alkyl, C1~C10 alkenyl or aryl, so The alkyl group is not necessarily substituted by halogen, alkoxy, aryl or heterocyclic group containing 1 to 2 O or N, such as pyrrolidinyl, piperidinyl, morpholinyl, piperazinyl, homopiperazine group, wherein the heterocyclic group may be optionally substituted by C1~C10 alkyl or C1~C10 alkoxy; and when Z is -O-, R 1 is methyl, R 2 is not methyl; Y is -N(R 5 ) 2 or -OR 5 , R 5 is selected from C1~C10 alkyl, C1~C10 alkenyl, aryl and C1~C10 alkyl substituted by aryl; R 8 can be a general amino group The protecting group is formyl, C1-C10 alkanoyl, aroyl, C1-C10 alkanoyl substituted by aryl, C1-C10 alkoxycarbonyl or C1-C10 alkoxycarbonyl substituted by aryl.

以上化合物中,R1优选为C1~C5烷基、乙酰基、丙酰基、苯甲酰基、叔丁氧羰基、苄基、苄氧羰基或三苯甲基;R2优选为甲基、乙基、丙基、苄基、-(CH2)n-Cl、-(CH2)n-Br、其中n=1~5,Alkyl为C1~C5烷基;X优选为氰基、三氟甲基、-NHCOOR3、-NHCOOR3、-N=CHR3、C1~C10烷氧羰基或羧基;Z优选为-NH-或-O-;Y优选-N(CH3)2、-OCH3、OC2H5;R8优选乙酰基、叔丁氧羰基、苄氧羰基。Among the above compounds, R1 is preferably C1~C5 alkyl, acetyl, propionyl, benzoyl, tert-butoxycarbonyl, benzyl, benzyloxycarbonyl or trityl; R2 is preferably methyl, ethyl , Propyl, Benzyl, -(CH 2 )n-Cl, -(CH 2 )n-Br, or Where n=1~5, Alkyl is C1~C5 alkyl; X is preferably cyano, trifluoromethyl, -NHCOOR 3 , -NHCOOR 3 , -N=CHR 3 , C1~C10 alkoxycarbonyl or carboxyl; Z Preferably -NH- or -O-; Y is preferably -N(CH 3 ) 2 , -OCH 3 , OC 2 H 5 ; R 8 is preferably acetyl, tert-butoxycarbonyl, benzyloxycarbonyl.

以上化合物进一步优选为:The above compounds are further preferably:

式II化合物优选:Compounds of formula II are preferably:

3’-乙酰胺基-4’-乙氧基-6’-硝基-2-溴苯乙酮;3'-acetamido-4'-ethoxy-6'-nitro-2-bromoacetophenone;

3’-苯甲酰胺基-4’-乙氧基-6’-硝基-2-溴苯乙酮;3'-benzamido-4'-ethoxy-6'-nitro-2-bromoacetophenone;

3’-苄胺基-4’-乙氧基-6’-硝基-2-溴苯乙酮;3'-Benzylamino-4'-ethoxy-6'-nitro-2-bromoacetophenone;

3’-甲氧基-4’-(4-甲基-1-哌嗪基)丙氧基-6’-硝基-2-溴苯乙酮;3'-methoxy-4'-(4-methyl-1-piperazinyl)propoxy-6'-nitro-2-bromoacetophenone;

式III化合物优选:Compounds of formula III are preferably:

3’-乙酰胺基-4’-乙氧基-2-溴苯乙酮;3'-acetamido-4'-ethoxy-2-bromoacetophenone;

3’-苯甲酰胺基-4’-乙氧基-2-溴苯乙酮;3'-benzamido-4'-ethoxy-2-bromoacetophenone;

3’-苄胺基-4’-乙氧基-2-溴苯乙酮;3'-Benzylamino-4'-ethoxy-2-bromoacetophenone;

3’-甲氧基-4’-(4-甲基-1-哌嗪基)丙氧基-2-溴苯乙酮;3'-methoxy-4'-(4-methyl-1-piperazinyl)propoxy-2-bromoacetophenone;

式IV化合物优选:Compounds of formula IV are preferably:

3’-乙酰胺基-4’-乙氧基-2-氰基苯乙酮;3'-acetamido-4'-ethoxy-2-cyanoacetophenone;

3’-苯甲酰胺基-4’-乙氧基-2-氰基苯乙酮;3'-benzamido-4'-ethoxy-2-cyanoacetophenone;

3’-苄胺基-4’-乙氧基-2-氰基苯乙酮;3'-Benzylamino-4'-ethoxy-2-cyanoacetophenone;

3’-甲氧基-4’-(4-甲基-1-哌嗪基)丙氧基-2-氰基苯乙酮;3'-methoxy-4'-(4-methyl-1-piperazinyl)propoxy-2-cyanoacetophenone;

式V化合物优选:Compounds of formula V are preferably:

3-(5-乙酰胺基-4-乙氧基-2-硝基苯基)-2-氰基-3-羰基-丙酸乙酯;3-(5-acetamido-4-ethoxy-2-nitrophenyl)-2-cyano-3-carbonyl-propionic acid ethyl ester;

2-(5-乙酰氨基-4-乙氧基-2-硝基苯甲酰基)丙二酸二乙酯;Diethyl 2-(5-acetylamino-4-ethoxy-2-nitrobenzoyl)malonate;

式VI化合物优选:Compounds of formula VI are preferably:

N-(5-(2-氰基-3-(二甲基胺基)丙烯酰基)-2-乙氧基-4-硝基苯基)乙酰胺;N-(5-(2-cyano-3-(dimethylamino)acryloyl)-2-ethoxy-4-nitrophenyl)acetamide;

N-(5-(2-氰基-3-(甲氧基)丙烯酰基)-2-乙氧基-4-硝基苯基)乙酰胺;N-(5-(2-cyano-3-(methoxy)acryloyl)-2-ethoxy-4-nitrophenyl)acetamide;

N-(5-(2-乙氧基羰基-3-(二甲基胺基)丙烯酰基)-2-乙氧基-4-硝基苯基)乙酰胺;N-(5-(2-ethoxycarbonyl-3-(dimethylamino)acryloyl)-2-ethoxy-4-nitrophenyl)acetamide;

式VIII化合物优选:Compounds of formula VIII are preferably:

3’-乙酰胺基-4’-乙氧基-6’-氨基-2-氰基苯乙酮;3'-acetamido-4'-ethoxy-6'-amino-2-cyanoacetophenone;

3’-苯甲酰胺基-4’-乙氧基-6’-氨基-2-氰基苯乙酮;3'-benzamido-4'-ethoxy-6'-amino-2-cyanoacetophenone;

3’-苄胺基-4’-乙氧基-6’-氨基-2-氰基苯乙酮;3'-Benzylamino-4'-ethoxy-6'-amino-2-cyanoacetophenone;

3’-甲氧基-4’-(4-甲基-1-哌嗪基)丙氧基-6’-氨基-2-氰基苯乙酮。3'-methoxy-4'-(4-methyl-1-piperazinyl)propoxy-6'-amino-2-cyanoacetophenone.

本发明实现的技术效果如下:The technical effect that the present invention realizes is as follows:

(1)在本发明中,用化合物I制备化合物A及A’的方法,相对于已有的喹啉环的制备的文献方法,可以避免使用高温条件,避免使用高沸点溶剂,环保而且安全。特别的,X=氰基或酯基时收率达到80%以上,明显优于现有的方法。(1) In the present invention, the method for preparing compound A and A' with compound I, compared to the literature method of the preparation of existing quinoline ring, can avoid using high temperature conditions, avoid using high boiling point solvent, environmental protection and safety. In particular, when X=cyano group or ester group, the yield can reach more than 80%, which is obviously superior to the existing methods.

(2)化合物I可由工业原料很方便、高产率地得到。(2) Compound I can be obtained from industrial raw materials conveniently and in high yield.

(3)反应的转化率高,操作简便,且反应条件温和。多步中间体不需分离纯化,可直接用于下步反应,极大地提高了收率,简化了操作。可以实现工业化生产。(3) The conversion rate of the reaction is high, the operation is simple and convenient, and the reaction conditions are mild. The multi-step intermediate does not need to be separated and purified, and can be directly used in the next step reaction, which greatly improves the yield and simplifies the operation. Industrialized production can be realized.

(4)在用化合物I制备化合物A或A’的方法中,优选方法(2),其反应条件温和,中间体稳定,更易纯化,收率较高,且成本大大降低。制备目标物A或A’的反应产生的杂质少,产物容易纯化,操作简便,总收率较高,更易实现工业化生产。(4) In the method for preparing compound A or A' with compound I, preferred method (2) has mild reaction conditions, stable intermediates, easier purification, higher yield, and greatly reduced cost. The reaction to prepare the target substance A or A' produces less impurities, the product is easy to purify, the operation is simple, the total yield is high, and it is easier to realize industrial production.

总之,通过本发明,实现了3-取代-4-羟基喹啉类化合物和3-取代-4-氯喹啉类化合物的全新的合成路线,条件温和,操作简易,安全有效。In a word, through the present invention, a brand-new synthetic route of 3-substituted-4-hydroxyquinoline compounds and 3-substituted-4-chloroquinoline compounds is realized, with mild conditions, simple operation, safe and effective.

具体实施方式 Detailed ways

通过以下实施例进一步说明本发明,以下实施例仅用于更具体说明本发明的优选实施方式,不用于对本发明的技术方案进行限定。上述本发明的技术方案均为可实现本发明目的的技术方案。即以下实施例所采用温度和试剂,均可用上文所述相应温度和试剂替代以实现本发明的目的。The present invention is further illustrated by the following examples, which are only used to more specifically illustrate preferred embodiments of the present invention, and are not intended to limit the technical solutions of the present invention. The above-mentioned technical solutions of the present invention are all technical solutions that can realize the purpose of the present invention. That is, the temperature and reagents used in the following examples can be replaced by the corresponding temperatures and reagents described above to achieve the purpose of the present invention.

下述制备例中,核磁共振由Bruker AMX-400型和INVOA-600型核磁共振仪测定,TMS为内标,化学位移单位为ppm;质谱由MAT-711型和MAT-95型质谱仪测定;柱层析用硅胶200-300目,青岛海洋化工厂生产;TLC硅胶板为烟台化工厂生产的HSGF-254型薄层层析预制板;石油醚沸程为60-90℃;采用紫外灯,碘缸显色。制备例中若未特别指出操作方法,所述浓缩指用旋转蒸发仪将制备化合物溶液中的溶剂蒸出;所述干燥指用DHG-9240A恒温干燥箱在60℃将制备化合物烘干。In the following preparation examples, nuclear magnetic resonance is measured by Bruker AMX-400 type and INVOA-600 type nuclear magnetic resonance instrument, TMS is an internal standard, and the chemical shift unit is ppm; Mass spectrum is measured by MAT-711 type and MAT-95 type mass spectrometer; The silica gel for column chromatography is 200-300 mesh, produced by Qingdao Ocean Chemical Factory; the TLC silica gel plate is the HSGF-254 thin layer chromatography prefabricated plate produced by Yantai Chemical Factory; the boiling range of petroleum ether is 60-90°C; Iodine cylinder color. If the operation method is not specified in the preparation examples, the concentration refers to evaporating the solvent in the solution of the prepared compound with a rotary evaporator; the drying refers to drying the prepared compound at 60° C. with a DHG-9240A constant temperature drying oven.

实施例一3-乙酰胺基-4-乙氧基苯乙酮(化合物B,R1=乙酰基,R2=乙基,Z=-NH-)的合成Example 1 Synthesis of 3-acetamido-4-ethoxyacetophenone (compound B, R 1 = acetyl, R 2 = ethyl, Z = -NH-)

(1)3-硝基-4-羟基苯乙酮的制备(1) Preparation of 3-nitro-4-hydroxyacetophenone

冰浴中,将对羟基苯乙酮(136.2g,1.0mol)加入到浓硫酸(1000ml)中,搅拌10min,加入硝酸钾(103.0g,1.02mol),搅拌2h,反应结束。将反应液倒入3000ml碎冰中,析出大量固体,抽滤,水洗,干燥,得淡黄色粉末的3-硝基-4-羟基苯乙酮171.2g,收率94.5%。In an ice bath, p-hydroxyacetophenone (136.2 g, 1.0 mol) was added to concentrated sulfuric acid (1000 ml), stirred for 10 min, potassium nitrate (103.0 g, 1.02 mol) was added, stirred for 2 h, and the reaction was completed. The reaction solution was poured into 3000ml of crushed ice, a large amount of solid was precipitated, suction filtered, washed with water, and dried to obtain 171.2g of 3-nitro-4-hydroxyacetophenone as light yellow powder with a yield of 94.5%.

(2)3-氨基-4-羟基苯乙酮的制备(2) Preparation of 3-amino-4-hydroxyacetophenone

常温下,将3-硝基-4-羟基苯乙酮(171.2g,0.945mol)溶于THF(1500ml)中,加入Raney Ni 20g,常压氢化反应24h,反应结束。过滤,浓缩,干燥,得黄褐色固体的3-氨基-4-羟基苯乙酮132.8g,收率93.0%。At room temperature, 3-nitro-4-hydroxyacetophenone (171.2g, 0.945mol) was dissolved in THF (1500ml), and Raney Ni 20g was added, hydrogenated at normal pressure for 24h, and the reaction was completed. Filter, concentrate, and dry to obtain 132.8 g of 3-amino-4-hydroxyacetophenone as a yellow-brown solid, with a yield of 93.0%.

(3)3-乙酰胺基-4-羟基苯乙酮的制备(3) Preparation of 3-acetamido-4-hydroxyacetophenone

将3-氨基-4-羟基苯乙酮(121.0g,0.8mol)溶于冰乙酸(1000ml)中,60℃搅拌,滴加乙酸酐(115.0ml,1.2mol),1h加完,再搅拌30min,反应结束。将反应液倒入2000ml冰水中,析出大量固体,搅拌放置2h,抽滤,水洗,干燥,得黄褐色粉末的3-乙酰胺基-4-羟基苯乙酮134.8g,收率87.2%。Dissolve 3-amino-4-hydroxyacetophenone (121.0g, 0.8mol) in glacial acetic acid (1000ml), stir at 60°C, add acetic anhydride (115.0ml, 1.2mol) dropwise, add 1h, then stir for 30min , the reaction ends. The reaction solution was poured into 2000ml of ice water, a large amount of solid precipitated out, stirred for 2 hours, suction filtered, washed with water, and dried to obtain 134.8g of 3-acetamido-4-hydroxyacetophenone as a yellowish brown powder with a yield of 87.2%.

(4)3-乙酰胺基-4-乙氧基苯乙酮的制备(4) Preparation of 3-acetamido-4-ethoxyacetophenone

将3-乙酰胺基-4-羟基苯乙酮(96.6g,0.5mol)和碳酸钾(138.2g,1.0mol)溶于DMF(500ml)中,60℃搅拌10min,滴加溴乙烷(60ml,0.75mol),1h加完,再搅拌30min,反应结束。将反应液倒入2000ml冰水中,用乙酸乙酯提取(600ml×4),水洗有机层,干燥,浓缩得灰褐色粉末的3-乙酰胺基-4-乙氧基苯乙酮(化合物B,R1=乙酰基,R2=乙基,Z=-NH-)100.9g,收率91.2%。1HNMR(300MHz,CDCl3)δ1.49(t,3H),2.22(s,3H),2.56(s,3H),4.19(q,2H),6.90(d,1H),7.74(m,2H),8.96(s,1H)。ESI-MS(m/z)222(M+1),244(M+23),260(M+39)。Dissolve 3-acetamido-4-hydroxyacetophenone (96.6g, 0.5mol) and potassium carbonate (138.2g, 1.0mol) in DMF (500ml), stir at 60°C for 10min, add bromoethane (60ml , 0.75mol), 1h added, and then stirred for 30min, the reaction ended. The reaction solution was poured into 2000ml ice water, extracted with ethyl acetate (600ml×4), the organic layer was washed with water, dried, and concentrated to obtain 3-acetamido-4-ethoxyacetophenone (compound B, R 1 = acetyl, R 2 = ethyl, Z = -NH-) 100.9 g, yield 91.2%. 1 HNMR (300MHz, CDCl 3 ) δ1.49(t, 3H), 2.22(s, 3H), 2.56(s, 3H), 4.19(q, 2H), 6.90(d, 1H), 7.74(m, 2H ), 8.96(s, 1H). ESI-MS (m/z) 222 (M+1), 244 (M+23), 260 (M+39).

实施例二3-乙酰胺基-4-乙氧基-6-硝基苯乙酮(化合物D,R1=乙酰基,R2=乙基,Z=-NH-)的合成Example 2 Synthesis of 3-acetamido-4-ethoxy-6-nitroacetophenone (compound D, R 1 = acetyl, R 2 = ethyl, Z = -NH-)

将化合物B(R1=乙酰基,R2=乙基,Z=-NH-)(88.5g,0.4mol)溶于硝基甲烷(1000ml)中,加入发烟硝酸(17.7ml,0.4mol),于40℃搅拌12h,补加发烟硝酸(15.5ml,0.35mol),搅拌10h,反应结束。将反应液倒入饱和碳酸氢钠溶液(1000ml)中,搅拌,分液,水洗有机层,干燥,过滤,滤液中加入10g活性炭,回流20min,热滤,浓缩得红色油状物,40℃常压干燥得淡红色固体的3-乙酰胺基-4-乙氧基-6-硝基苯乙酮(化合物D,R1=乙酰基,R2=乙基,Z=-NH-)86.5g,收率81.2%。1HNMR(300MHz,CDCl3)δ1.52(t,3H),2.24(s,3H),2.52(s,3H),4.22(q,2H),7.53(s,1H),7.98(s,1H),8.52(s,1H)。ESI-MS(m/z)265(M-1)。Compound B (R 1 =acetyl, R 2 =ethyl, Z=-NH-) (88.5g, 0.4mol) was dissolved in nitromethane (1000ml), and fuming nitric acid (17.7ml, 0.4mol) was added , stirred at 40°C for 12h, added fuming nitric acid (15.5ml, 0.35mol), stirred for 10h, and the reaction ended. Pour the reaction solution into saturated sodium bicarbonate solution (1000ml), stir, separate liquids, wash the organic layer with water, dry, filter, add 10g of activated carbon to the filtrate, reflux for 20min, heat filter, concentrate to obtain a red oily substance, 40°C under normal pressure 86.5 g of 3-acetamido-4-ethoxy-6-nitroacetophenone (compound D, R 1 = acetyl, R 2 = ethyl, Z = -NH-) was dried as a light red solid, Yield 81.2%. 1 HNMR (300MHz, CDCl 3 ) δ1.52(t, 3H), 2.24(s, 3H), 2.52(s, 3H), 4.22(q, 2H), 7.53(s, 1H), 7.98(s, 1H ), 8.52(s, 1H). ESI-MS (m/z) 265 (M-1).

实施例三3’-乙酰胺基-4’-乙氧基-6’-硝基-2-溴苯乙酮(化合物II,R1=乙酰基,R2=乙基,Z=-NH-)的合成Example 3 3'-acetamido-4'-ethoxy-6'-nitro-2-bromoacetophenone (Compound II, R 1 =acetyl, R 2 =ethyl, Z=-NH- )Synthesis

将化合物D(R1=乙酰基,R2=乙基,Z=-NH-)(79.9g,0.3mol)溶于二氯甲烷(1000ml)中,加入液溴(15.7ml,0.306mol),常温搅拌12h,反应液由淡红色变为淡黄色,反应结束。浓缩得淡红色油状物的3’-乙酰胺基-4’-乙氧基-6’-硝基-2-溴苯乙酮(化合物II,R1=乙酰基,R2=乙基,Z=-NH-)110.0g,可直接用于下一步反应。1HNMR(300MHz,CDCl3)δ1.55(t,3H),2.24(s,3H),4.27(q,2H),4.30(s,2H),7.64(s,1H),8.01(s,1H),8.58(s,1H)。ESI-MS(m/z)346(M+1),368(M+23)。Compound D (R 1 = acetyl, R 2 = ethyl, Z = -NH-) (79.9 g, 0.3 mol) was dissolved in dichloromethane (1000 ml), liquid bromine (15.7 ml, 0.306 mol) was added, After stirring at room temperature for 12 hours, the reaction solution changed from light red to light yellow, and the reaction was completed. 3'-acetamido-4'-ethoxy-6'-nitro-2-bromoacetophenone (compound II, R 1 = acetyl, R 2 = ethyl, Z =-NH-) 110.0g, can be directly used in the next reaction. 1 HNMR (300MHz, CDCl 3 ) δ1.55(t, 3H), 2.24(s, 3H), 4.27(q, 2H), 4.30(s, 2H), 7.64(s, 1H), 8.01(s, 1H ), 8.58(s, 1H). ESI-MS (m/z) 346 (M+1), 368 (M+23).

实施例四3’-乙酰胺基-4’-乙氧基-6’-硝基-2-氰基苯乙酮(化合物I,R1=乙酰基,R2=乙基,X=氰基,Z=-NH-)的合成Example 4 3'-acetamido-4'-ethoxy-6'-nitro-2-cyanoacetophenone (compound I, R 1 = acetyl, R 2 = ethyl, X = cyano , Z=-NH-) synthesis

将化合物II(R1=乙酰基,R2=乙基,Z=-NH-)(110.0g,0.3mol)溶于乙醇(600ml)和DMSO(200ml)中,冰浴冷却,滴加氰化钠(29.4g,0.6mol)的水(300ml)溶液,1h加完,反应液呈黑褐色,常温反应6h,反应结束。将反应液倒入2000ml水中,用1M盐酸调溶液pH值为5,析出大量固体,抽滤,水洗,干燥,得灰黄色粉末的3’-乙酰胺基-4’-乙氧基-6’-硝基-2-氰基苯乙酮(化合物I,R1=乙酰基,R2=乙基,X=氰基,Z=-NH-)68.3g,收率78.2%。1HNMR(300MHz,CDCl3)δ1.56(t,3H),2.28(s,3H),3.85(s,2H),4.28(q,2H),7.64(s,1H),8.02(s,1H),8.58(s,1H)。ESI-MS(m/z)290(M-1)。Compound II (R 1 = acetyl, R 2 = ethyl, Z = -NH-) (110.0 g, 0.3 mol) was dissolved in ethanol (600 ml) and DMSO (200 ml), cooled in an ice bath, and cyanide was added dropwise Sodium (29.4g, 0.6mol) in water (300ml) solution was added after 1 hour, and the reaction solution was dark brown. After 6 hours at room temperature, the reaction was completed. Pour the reaction solution into 2000ml of water, adjust the pH value of the solution to 5 with 1M hydrochloric acid, precipitate a large amount of solid, suction filter, wash with water, and dry to obtain 3'-acetamido-4'-ethoxy-6' as grayish yellow powder -Nitro-2-cyanoacetophenone (compound I, R 1 = acetyl, R 2 = ethyl, X = cyano, Z = -NH-) 68.3 g, yield 78.2%. 1 HNMR (300MHz, CDCl 3 ) δ1.56(t, 3H), 2.28(s, 3H), 3.85(s, 2H), 4.28(q, 2H), 7.64(s, 1H), 8.02(s, 1H ), 8.58(s, 1H). ESI-MS (m/z) 290 (M-1).

实施例五 N-(5-(2-氰基-3-(二甲基胺基)丙烯酰基)-2-乙氧基-4-硝基苯基)乙酰胺(化合物VI,R1=乙酰基,R2=乙基,X=氰基,Y=-N(CH3)2,Z=-NH-)的合成Example 5 N-(5-(2-cyano-3-(dimethylamino)acryloyl)-2-ethoxy-4-nitrophenyl)acetamide (compound VI, R 1 =acetyl group, R 2 = ethyl, X = cyano, Y = -N(CH 3 ) 2 , Z = -NH-)

将化合物I(R1=乙酰基,R2=乙基,X=氰基,Z=-NH-)(58.3g,0.2mol)溶于乙二醇二甲醚(600ml)中,加入N,N-二甲酰胺二甲缩醛(DMF-DMA)(29.2ml,0.22mol),室温搅拌,反应液中逐渐析出淡黄色粉末,1h后反应结束。抽滤,洗涤,干燥,得淡黄色粉末的N-(5-(2-氰基-3-(二甲基胺基)丙烯酰基)-2-乙氧基-4-硝基苯基)乙酰胺(化合物VI,R1=乙酰基,R2=乙基,X=氰基,Y=-N(CH3)2,Z=-NH-)93.0g,收率91.0%。1HNMR(300MHz,DMSO)δ1.43(t,3H),2.17(s,3H),3.27(s,3H),3.31(s,3H),4.28(q,2H),7.73(s,1H),8.26(s,1H),9.52(s,1H)。ESI-MS(m/z)345(M-1)。Compound I (R 1 = acetyl, R 2 = ethyl, X = cyano, Z = -NH-) (58.3 g, 0.2 mol) was dissolved in ethylene glycol dimethyl ether (600 ml), N was added, N-Diformamide dimethyl acetal (DMF-DMA) (29.2ml, 0.22mol) was stirred at room temperature, a light yellow powder gradually precipitated out of the reaction solution, and the reaction ended after 1h. Suction filtration, washing, and drying to obtain N-(5-(2-cyano-3-(dimethylamino)acryloyl)-2-ethoxy-4-nitrophenyl)ethane as light yellow powder Amide (compound VI, R 1 = acetyl, R 2 = ethyl, X = cyano, Y = -N(CH 3 ) 2 , Z = -NH-) 93.0 g, yield 91.0%. 1 HNMR (300MHz, DMSO) δ1.43(t, 3H), 2.17(s, 3H), 3.27(s, 3H), 3.31(s, 3H), 4.28(q, 2H), 7.73(s, 1H) , 8.26(s, 1H), 9.52(s, 1H). ESI-MS (m/z) 345 (M-1).

实施例六 6-乙酰胺基-7-乙氧基-3-氰基-4-羟基喹啉(化合物A,R1=乙酰基,R2=乙基,X=氰基,Z=-NH-)的合成Example 6 6-acetamido-7-ethoxy-3-cyano-4-hydroxyquinoline (compound A, R 1 = acetyl, R 2 = ethyl, X = cyano, Z = -NH -)Synthesis

将化合物VI(R1=乙酰基,R2=乙基,X=氰基,Y=-N(CH3)2,Z=-NH-)(34.6g,0.1mol)溶于DMF(300ml),加入Raney Ni 6g,常压氢化反应3h,反应结束。过滤,滤液浓缩至一半体积,再用水(600ml)稀释,析出固体,室温放置过夜,抽滤,水洗,干燥,得淡黄色粉末的6-乙酰胺基-7-乙氧基-3-氰基-4-羟基喹啉(化合物A,R1=乙酰基,R2=乙基,X=氰基,Z=-NH-)16.6g,收率61%。1HNMR(300MHz,DMSO)δ1.45(t,3H),2.14(s,3H),4.20(q,2H),7.05(s,1H),8.60(s,1H),8.70(s,1H),9.21(s,1H),12.58(s,1H)。ESI-Ms(m/z)270(M-1)。Compound VI (R 1 = acetyl, R 2 = ethyl, X = cyano, Y = -N(CH 3 ) 2 , Z = -NH-) (34.6 g, 0.1 mol) was dissolved in DMF (300 ml) , add Raney Ni 6g, hydrogenation reaction at normal pressure for 3h, and the reaction ends. Filtrate, concentrate the filtrate to half its volume, then dilute with water (600ml) to precipitate a solid, leave it overnight at room temperature, filter with suction, wash with water, and dry to obtain 6-acetamido-7-ethoxy-3-cyano as a light yellow powder - 4-Hydroxyquinoline (compound A, R 1 = acetyl, R 2 = ethyl, X = cyano, Z = -NH-) 16.6 g, yield 61%. 1 HNMR (300MHz, DMSO) δ1.45(t, 3H), 2.14(s, 3H), 4.20(q, 2H), 7.05(s, 1H), 8.60(s, 1H), 8.70(s, 1H) , 9.21(s, 1H), 12.58(s, 1H). ESI-Ms (m/z) 270 (M-1).

实施例七 6-乙酰胺基-7-乙氧基-3-氰基-4-羟基喹啉(化合物A,R1=乙酰基,R2=乙基,X=氰基,Z=-NH-)的合成Example 7 6-acetamido-7-ethoxy-3-cyano-4-hydroxyquinoline (compound A, R 1 = acetyl, R 2 = ethyl, X = cyano, Z = -NH -)Synthesis

将化合物VI(R1=乙酰基,R2=乙基,X=氰基,Y=-N(CH3)2,Z=-NH-)(5.0g,0.0144mol)溶于DMF(60ml)和乙醇(10ml),加入氯化钙(7.2g,0.0648mol)的水(10ml)溶液,加入还原铁粉(3.6g,0.0648mol),75℃反应,6h后反应结束,加入活性炭(0.5g),于75℃脱色20min。抽滤,滤液浓缩至一半体积,滤液倒入碎冰(100g)中,放置1h,析出土黄色固体,抽滤,水洗,干燥得土黄色固体6-乙酰胺基-7-乙氧基-3-氰基-4-羟基喹啉(化合物A,R1=乙酰基,R2=乙基,X=氰基,Z=-NH-)3.1g,收率79%。1HNMR(300MHz,DMSO)δ1.45(t,3H),2.14(s,3H),4.20(q,2H),7.05(s,1H),8.60(s,1H),8.70(s,1H),9.21(s,1H),12.58(s,1H)。ESI-Ms(m/z)270(M-1)。Compound VI (R 1 = acetyl, R 2 = ethyl, X = cyano, Y = -N(CH 3 ) 2 , Z = -NH-) (5.0 g, 0.0144 mol) was dissolved in DMF (60 ml) and ethanol (10ml), add calcium chloride (7.2g, 0.0648mol) in water (10ml) solution, add reduced iron powder (3.6g, 0.0648mol), react at 75°C, after 6h the reaction is over, add activated carbon (0.5g ), decolorize at 75°C for 20min. Suction filtration, the filtrate was concentrated to half volume, the filtrate was poured into crushed ice (100g), and left for 1h, a khaki solid was precipitated, suction filtered, washed with water, and dried to obtain a khaki solid 6-acetamido-7-ethoxy-3 -Cyano-4-hydroxyquinoline (compound A, R 1 =acetyl, R 2 =ethyl, X = cyano, Z = -NH-) 3.1 g, yield 79%. 1 HNMR (300MHz, DMSO) δ1.45(t, 3H), 2.14(s, 3H), 4.20(q, 2H), 7.05(s, 1H), 8.60(s, 1H), 8.70(s, 1H) , 9.21(s, 1H), 12.58(s, 1H). ESI-Ms (m/z) 270 (M-1).

实施例八 N-(5-(2-氰基-3-(甲氧基)丙烯酰基)-2-乙氧基-4-硝基苯基)乙酰胺(化合物VI,R1=乙酰基,R2=乙基,X=氰基,Y=-OCH3,Z=-NH-)的合成Example 8 N-(5-(2-cyano-3-(methoxy)acryloyl)-2-ethoxy-4-nitrophenyl)acetamide (compound VI, R 1 =acetyl, Synthesis of R 2 = ethyl, X = cyano, Y = -OCH 3 , Z = -NH-)

将化合物I(R1=乙酰基,R2=乙基,X=氰基,Z=-NH-)(58.3g,0.2mol)悬浮于乙二醇二甲醚(600ml)中,加入原甲酸三甲酯(化合物E,Y=OCH3)(63.6g,0.6mol),通氮气保护,加热回流,5-6h反应结束。蒸出溶剂得棕黄色固体,用乙酸乙酯/石油醚重结晶,得淡黄色粉末的N-(5-(2-氰基-3-(甲氧基)丙烯酰基)-2-乙氧基-4-硝基苯基)乙酰胺(化合物VI,R1=乙酰基,R2=乙基,X=氰基,Y=-OCH3,Z=-NH-)50.2g,收率81%。1HNMR(300MHz,DMSO)δ1.46(t,3H),2.18(s,3H),4.12(s,3H),4.31(q,2H),7.81(s,1H),8.13(s,1H),8.30(s,1H),9.64(s,1H)。ESI-MS(m/z)334(M+1)。Compound I (R 1 = acetyl, R 2 = ethyl, X = cyano, Z = -NH-) (58.3 g, 0.2 mol) was suspended in ethylene glycol dimethyl ether (600 ml), and orthoformic acid was added Trimethyl ester (compound E, Y=OCH 3 ) (63.6 g, 0.6 mol) was protected by nitrogen gas, heated to reflux, and the reaction was completed within 5-6 hours. The solvent was distilled off to obtain a brownish-yellow solid, which was recrystallized from ethyl acetate/petroleum ether to obtain N-(5-(2-cyano-3-(methoxy)acryloyl)-2-ethoxy -4-nitrophenyl)acetamide (Compound VI, R 1 =acetyl, R 2 =ethyl, X = cyano, Y = -OCH 3 , Z = -NH-) 50.2g, yield 81% . 1 HNMR (300MHz, DMSO) δ1.46(t, 3H), 2.18(s, 3H), 4.12(s, 3H), 4.31(q, 2H), 7.81(s, 1H), 8.13(s, 1H) , 8.30(s, 1H), 9.64(s, 1H). ESI-MS (m/z) 334 (M+1).

实施例九 6-乙酰胺基-7-乙氧基-3-氰基-4-羟基喹啉(化合物A,R1=乙酰基,R2=乙基,X=氰基,Z=-NH-)的合成Example 9 6-acetamido-7-ethoxy-3-cyano-4-hydroxyquinoline (compound A, R 1 = acetyl, R 2 = ethyl, X = cyano, Z = -NH -)Synthesis

将化合物VI(R1=乙酰基,R2=乙基,X=氰基,Y=-OCH3,Z=-NH-)(30.5g,0.1mol)溶于DMF(300ml),加入Raney Ni 6g,常压氢化反应4h,反应结束。过滤,滤液浓缩至一半体积,再用水(600ml)稀释,析出白色固体,室温放置过夜,抽滤,水洗,干燥,得淡黄色粉末的6-乙酰胺基-7-乙氧基-3-氰基-4-羟基喹啉(化合物A,R1=乙酰基,R2=乙基,X=氰基,Z=-NH-)20.5g,收率76%。1HNMR(300MHz,DMSO)δ1.45(t,3H),2.14(s,3H),4.20(q,2H),7.05(s,1H),8.60(s,1H),8.70(s,1H),9.21(s,1H),12.58(s,1H)。ESI-Ms(m/z)270(M-1)。Compound VI (R 1 = acetyl, R 2 = ethyl, X = cyano, Y = -OCH 3 , Z = -NH-) (30.5 g, 0.1 mol) was dissolved in DMF (300 ml), and Raney Ni 6g, atmospheric pressure hydrogenation reaction 4h, the reaction is over. Filtrate, concentrate the filtrate to half its volume, and then dilute with water (600ml) to precipitate a white solid, leave it overnight at room temperature, filter with suction, wash with water, and dry to obtain 6-acetamido-7-ethoxy-3-cyanide as a pale yellow powder 20.5 g of 4-hydroxyquinoline (compound A, R 1 = acetyl, R 2 = ethyl, X = cyano, Z = -NH-), yield 76%. 1 HNMR (300MHz, DMSO) δ1.45(t, 3H), 2.14(s, 3H), 4.20(q, 2H), 7.05(s, 1H), 8.60(s, 1H), 8.70(s, 1H) , 9.21(s, 1H), 12.58(s, 1H). ESI-Ms (m/z) 270 (M-1).

实施例十 3’-乙酰胺基-4’-乙氧基-2-溴苯乙酮(化合物III,R1=乙酰基,R2=乙基,Z=-NH-)的合成Example 10 Synthesis of 3'-acetamido-4'-ethoxy-2-bromoacetophenone (compound III, R 1 = acetyl, R 2 = ethyl, Z = -NH-)

将化合物B(R1=乙酰基,R2=乙基,Z=-NH-)(66.4g,0.3mol)溶于二氯甲烷(1000ml)中,加入液溴(15.7ml,0.306mol),常温搅拌2h,反应液中析出灰色固体,反应结束。浓缩反应液至300mL,抽滤、洗涤、干燥,得灰色固体的3’-乙酰胺基-4’-乙氧基-2-溴苯乙酮(化合物III,R1=乙酰基,R2=乙基,Z=-NH-)98.0g,产率80%。1HNMR(300MHz,CDCl3)δ1.56(t,3H),2.28(s,3H),3.85(s,2H),4.28(q,2H),7.64(s,1H),8.02(s,1H),8.58(s,1H)。EI-MS(m/z)300(M+),299(M-1)。Compound B (R 1 =acetyl, R 2 =ethyl, Z=-NH-) (66.4g, 0.3mol) was dissolved in dichloromethane (1000ml), liquid bromine (15.7ml, 0.306mol) was added, After stirring at room temperature for 2 h, a gray solid precipitated out of the reaction solution, and the reaction was completed. Concentrate the reaction solution to 300 mL, suction filter, wash, and dry to obtain 3'-acetamido-4'-ethoxy-2-bromoacetophenone (compound III, R 1 = acetyl, R 2 = Ethyl, Z=-NH-) 98.0 g, yield 80%. 1 HNMR (300MHz, CDCl 3 ) δ1.56(t, 3H), 2.28(s, 3H), 3.85(s, 2H), 4.28(q, 2H), 7.64(s, 1H), 8.02(s, 1H ), 8.58(s, 1H). EI-MS (m/z) 300 (M + ), 299 (M-1).

实施例十一 3’-乙酰胺基-4’-乙氧基-6’-硝基-2-溴苯乙酮(化合物II,R1=乙酰基,R2=乙基,Z=-NH-)的合成Example 11 3'-acetamido-4'-ethoxy-6'-nitro-2-bromoacetophenone (compound II, R 1 = acetyl, R 2 = ethyl, Z = -NH -)Synthesis

将化合物III(R1=乙酰基,R2=乙基,Z=-NH-)(98.0g,0.3mol)溶于硝基甲烷(1000ml)中,加入发烟硝酸(15.1ml,0.36mol),于40℃搅拌5h,补加发烟硝酸(13.3ml,0.3mol),搅拌2h,反应结束。将反应液倒入饱和碳酸氢钠溶液(1000ml)中,搅拌,水洗有机层,干燥,过滤,滤液中加入10g活性炭,回流20min,热滤,浓缩得褐色油状物,40℃常压干燥得褐色固体的3’-乙酰胺基-4’-乙氧基-6’-硝基-2-溴苯乙酮(化合物II,R1=乙酰基,R2=乙基,Z=-NH-)86.1g,收率83.2%。1HNMR(300MHz,CDCl3)δ1.55(t,3H),2.24(s,3H),4.27(q,2H),4.30(s,2H),7.64(s,1H),8.01(s,1H),8.58(s,1H)。ESI-MS(m/z)346(M+1),368(M+23)。Compound III (R 1 = acetyl, R 2 = ethyl, Z = -NH-) (98.0 g, 0.3 mol) was dissolved in nitromethane (1000 ml), and fuming nitric acid (15.1 ml, 0.36 mol) was added , stirred at 40°C for 5h, added fuming nitric acid (13.3ml, 0.3mol), stirred for 2h, and the reaction ended. Pour the reaction solution into saturated sodium bicarbonate solution (1000ml), stir, wash the organic layer with water, dry, filter, add 10g of activated carbon to the filtrate, reflux for 20min, heat filter, concentrate to obtain a brown oil, dry at 40°C under normal pressure to obtain a brown Solid 3'-acetamido-4'-ethoxy-6'-nitro-2-bromoacetophenone (compound II, R 1 = acetyl, R 2 = ethyl, Z = -NH-) 86.1 g, yield 83.2%. 1 HNMR (300MHz, CDCl 3 ) δ1.55(t, 3H), 2.24(s, 3H), 4.27(q, 2H), 4.30(s, 2H), 7.64(s, 1H), 8.01(s, 1H ), 8.58(s, 1H). ESI-MS (m/z) 346 (M+1), 368 (M+23).

实施例十二 3’-乙酰胺基-4’-乙氧基-6’-硝基-2-氰基苯乙酮(化合物I,R1=乙酰基,R2=乙基,X=氰基,Z=-NH-)的合成Example 12 3'-acetamido-4'-ethoxy-6'-nitro-2-cyanoacetophenone (compound I, R 1 = acetyl, R 2 = ethyl, X = cyano base, Z=-NH-) synthesis

将化合物II(R1=乙酰基,R2=乙基,Z=-NH-)(110.0g,0.3mol)溶于乙醇(600ml)和DMSO(200ml)中,固体未全溶,冰浴冷却,滴加氰化钠(29.4g,0.6mol)的水(300ml)溶液,1h加完,常温反应6h,反应结束。将反应液倒入2000ml水中,用1M盐酸调溶液pH值为5,析出大量固体,抽滤,水洗,干燥,得淡黄色粉末的3’-乙酰胺基-4’-乙氧基-6’-硝基-2-氰基苯乙酮(化合物I,R1=乙酰基,R2=乙基,X=氰基,Z=-NH-)68.3g,收率80%。1HNMR(300MHz,CDCl3)δ1.56(t,3H),2.28(s,3H),3.85(s,2H),4.28(q,2H),7.64(s,1H),8.02(s,1H),8.58(s,1H)。Compound II (R 1 = acetyl, R 2 = ethyl, Z = -NH-) (110.0 g, 0.3 mol) was dissolved in ethanol (600 ml) and DMSO (200 ml), the solid was not fully dissolved, cooled in an ice bath , Add a solution of sodium cyanide (29.4g, 0.6mol) in water (300ml) dropwise, finish adding in 1h, react at room temperature for 6h, and the reaction ends. Pour the reaction solution into 2000ml of water, adjust the pH value of the solution to 5 with 1M hydrochloric acid, precipitate a large amount of solid, suction filter, wash with water, and dry to obtain 3'-acetamido-4'-ethoxy-6' as light yellow powder -Nitro-2-cyanoacetophenone (compound I, R 1 =acetyl, R2 = ethyl, X = cyano, Z = -NH-) 68.3 g, yield 80%. 1 HNMR (300MHz, CDCl 3 ) δ1.56(t, 3H), 2.28(s, 3H), 3.85(s, 2H), 4.28(q, 2H), 7.64(s, 1H), 8.02(s, 1H ), 8.58(s, 1H).

实施例十三 3’-乙酰胺基-4’-乙氧基-2-氰基苯乙酮(化合物IV,R1=乙酰基,R2=乙基,X=氰基,Z=-NH-)的合成Example 13 3'-acetamido-4'-ethoxy-2-cyanoacetophenone (compound IV, R 1 = acetyl, R 2 = ethyl, X = cyano, Z = -NH -)Synthesis

将化合物III(R1=乙酰基,R2=乙基,Z=-NH-)(98.0g,0.3mol)溶于乙醇(500ml)和DMSO(300ml)中,固体未全溶,冰浴冷却,滴加氰化钠(29.4g,0.6mol)的水(300ml)溶液,1h加完,反应液中的固体逐渐溶解,常温反应2h,反应结束。将反应液倒入2000ml水中,用1M盐酸调溶液pH值为5,析出大量固体,抽滤,水洗,干燥,得淡黄色粉末的3’-乙酰胺基-4’-乙氧基-2-氰基苯乙酮(化合物IV,R1=乙酰基,R2=乙基,X=氰基,Z=-NH-)57.0g,收率77.2%。1HNMR(300MHz,DMSO)δ1.38(t,3H),2.11(s,3H),4.22(q,2H),4.67(s,2H),7.18(d,1H),7.70(m,1H),8.54(s,1H),9.17(s,1H)。EI-MS(m/z)246(M+)。Compound III (R 1 = acetyl, R 2 = ethyl, Z = -NH-) (98.0 g, 0.3 mol) was dissolved in ethanol (500 ml) and DMSO (300 ml), the solid was not fully dissolved, cooled in an ice bath , Add a solution of sodium cyanide (29.4g, 0.6mol) in water (300ml) dropwise, after 1h, the solids in the reaction solution gradually dissolve, react at room temperature for 2h, and the reaction ends. The reaction solution was poured into 2000ml of water, and the pH of the solution was adjusted to 5 with 1M hydrochloric acid. A large amount of solid precipitated, filtered with suction, washed with water, and dried to obtain 3'-acetamido-4'-ethoxy-2- Cyanoacetophenone (compound IV, R 1 = acetyl, R 2 = ethyl, X = cyano, Z = -NH-) 57.0 g, yield 77.2%. 1 HNMR (300MHz, DMSO) δ1.38(t, 3H), 2.11(s, 3H), 4.22(q, 2H), 4.67(s, 2H), 7.18(d, 1H), 7.70(m, 1H) , 8.54(s, 1H), 9.17(s, 1H). EI-MS (m/z) 246 (M + ).

实施例十四3’-乙酰胺基-4’-乙氧基-6’-硝基-2-氰基苯乙酮(化合物I,R1=乙酰基,R2=乙基,X=氰基,Z=-NH-)的合成Example 14 3'-acetamido-4'-ethoxy-6'-nitro-2-cyanoacetophenone (compound I, R 1 = acetyl, R 2 = ethyl, X = cyano base, Z=-NH-) synthesis

将化合物IV(R1=乙酰基,R2=乙基,X=氰基,Z=-NH-)(73.8g,0.3mol)溶于硝基甲烷(l000ml)中,加入发烟硝酸(15.1ml,0.36mol),搅拌2h,补加发烟硝酸(13.3ml,0.3mol),搅拌5h,反应结束。将反应液倒入饱和碳酸氢钠溶液(1000ml)中,搅拌,水洗有机层,干燥,过滤,滤液中加入10g活性炭,回流20min,热滤,浓缩,干燥,得到褐色固体的3’-乙酰胺基-4’-乙氧基-6’-硝基-2-氰基苯乙酮(化合物I,R1=乙酰基,R2=乙基,X=氰基,Z=-NH-)71g,产率81%。1HNMR(300MHz,CDCl3)δ1.56(t,3H),2.28(s,3H),3.85(s,2H),4.28(q,2H),7.64(s,1H),8.02(s,1H),8.58(s,1H)。Compound IV (R 1 = acetyl, R 2 = ethyl, X = cyano, Z = -NH-) (73.8 g, 0.3 mol) was dissolved in nitromethane (1000 ml), fuming nitric acid (15.1 ml, 0.36mol), stirred for 2h, added fuming nitric acid (13.3ml, 0.3mol), stirred for 5h, and the reaction ended. Pour the reaction solution into saturated sodium bicarbonate solution (1000ml), stir, wash the organic layer with water, dry, filter, add 10g of activated carbon to the filtrate, reflux for 20min, heat filter, concentrate, and dry to obtain 3'-acetamide as a brown solid Acyl-4'-ethoxy-6'-nitro-2-cyanoacetophenone (compound I, R 1 = acetyl, R 2 = ethyl, X = cyano, Z = -NH-) 71g , yield 81%. 1 HNMR (300MHz, CDCl 3 ) δ1.56(t, 3H), 2.28(s, 3H), 3.85(s, 2H), 4.28(q, 2H), 7.64(s, 1H), 8.02(s, 1H ), 8.58(s, 1H).

实施例十五 3-(5-乙酰胺基-4-乙氧基-2-硝基苯基)-2-氰基-3-羰基-丙酸乙酯(化合物V,R1=乙酰基,R2=乙基,R4=乙基,X=氰基,Z=-NH-)的合成Example 15 3-(5-acetamido-4-ethoxy-2-nitrophenyl)-2-cyano-3-carbonyl-propionic acid ethyl ester (compound V, R 1 = acetyl, Synthesis of R 2 = ethyl, R 4 = ethyl, X = cyano, Z = -NH-)

将3-胺基-4-羟基苯甲酸甲酯(133.7g,0.8mol)溶于冰乙酸(1000mL)中,60℃搅拌,未全溶,滴加乙酸酐(115.0mL,1.2mol),1h加完,反应结束,析出大量固体。将反应液倒入2000mL冰水中,析出大量固体,搅拌放置1h,抽滤,水洗,干燥,得乳白色固体的3-乙酰胺基-4-羟基苯甲酸甲酯154.3g,收率92.2%。Dissolve 3-amino-4-hydroxybenzoic acid methyl ester (133.7g, 0.8mol) in glacial acetic acid (1000mL), stir at 60°C, if not fully dissolved, add acetic anhydride (115.0mL, 1.2mol) dropwise, 1h After the addition was complete, the reaction ended, and a large amount of solid was precipitated. The reaction solution was poured into 2000 mL of ice water, a large amount of solids were precipitated, stirred for 1 h, filtered with suction, washed with water, and dried to obtain 154.3 g of methyl 3-acetamido-4-hydroxybenzoate as a milky white solid, with a yield of 92.2%.

将3-乙酰胺基-4-羟基苯甲酸甲酯(104.6g,0.5mol)和碳酸钾(138.2g,1.0mol)溶于DMF(500mL)中,60℃搅拌10min,未全溶,滴加溴乙烷(60.0mL,0.75mol),1h加完,反应结束,析出大量固体。将反应液倒入2000mL冰水中,析出大量固体,抽滤,水洗,干燥,得淡粉色固体的3-乙酰胺基-4-乙氧基苯甲酸甲酯112.0g,收率94.5%。1H-NMR(300MHz,CDCl3)δ1.47(t,3H),2.21(s,3H),3.87(s,3H),4.15(q,2H),6.87(d,1H),7.70(s,1H),7.77(dd,1H),8.97(d,1H)。ESI-MS(m/z)238(M+1),260(M+23)。Dissolve methyl 3-acetamido-4-hydroxybenzoate (104.6g, 0.5mol) and potassium carbonate (138.2g, 1.0mol) in DMF (500mL), stir at 60°C for 10min, until they are not completely dissolved, add dropwise Ethyl bromide (60.0 mL, 0.75 mol) was added after 1 h, and the reaction was completed, and a large amount of solids were precipitated. The reaction solution was poured into 2000 mL of ice water, a large amount of solid precipitated out, suction filtered, washed with water, and dried to obtain 112.0 g of methyl 3-acetamido-4-ethoxybenzoate as a pale pink solid, with a yield of 94.5%. 1 H-NMR (300MHz, CDCl 3 ) δ1.47(t, 3H), 2.21(s, 3H), 3.87(s, 3H), 4.15(q, 2H), 6.87(d, 1H), 7.70(s , 1H), 7.77 (dd, 1H), 8.97 (d, 1H). ESI-MS (m/z) 238 (M+1), 260 (M+23).

常温下将3-乙酰胺基-4-乙氧基苯甲酸甲酯(95.0g,0.4mol)溶于硝基甲烷(1500mL)中,加入发烟硝酸(50.0mL,1.2mol),于30℃搅拌3h,反应结束。将反应液倒入碳酸钠(80.0g,0.75mol)水溶液(1200mL)中,搅拌,分液,水洗有机层,干燥,蒸出溶剂得淡红棕色固体的3-乙酰胺基-4-乙氧基-6-硝基苯甲酸甲酯104.0g,收率92.0%。1H-NMR(300MHz,CDCl3)δ1.52(t,3H),2.25(s,3H),3.88(s,3H),4.22(q,2H),7.44(s,1H),7.90(s,1H),8.74(s,1H)。ESI-MS(m/z)283(M+1),305(M+23)。Dissolve methyl 3-acetamido-4-ethoxybenzoate (95.0 g, 0.4 mol) in nitromethane (1500 mL) at room temperature, add fuming nitric acid (50.0 mL, 1.2 mol), and Stirred for 3h, the reaction ended. Pour the reaction solution into sodium carbonate (80.0g, 0.75mol) aqueous solution (1200mL), stir, separate the layers, wash the organic layer with water, dry, evaporate the solvent to obtain 3-acetamido-4-ethoxy 104.0 g of methyl-6-nitrobenzoate, yield 92.0%. 1 H-NMR (300MHz, CDCl 3 ) δ1.52(t, 3H), 2.25(s, 3H), 3.88(s, 3H), 4.22(q, 2H), 7.44(s, 1H), 7.90(s , 1H), 8.74 (s, 1H). ESI-MS (m/z) 283 (M+1), 305 (M+23).

将3-乙酰胺基-4-乙氧基-6-硝基苯甲酸甲酯(85.0g,0.3mol)溶于THF(500mL)和10%氢氧化钠水溶液(500mL,1.3mol),回流反应4h,反应结束。冷却至室温,反应液分层,上层为淡黄色,下层为黑褐色,分液,下层用冰乙酸调pH值为4-5,乙酸乙酯提取(200mL×5次),水洗有机层,干燥,蒸出溶剂得褐色块状固体的3-胺基-4-乙氧基-6-硝基苯甲酸甲酯63.8g,收率94%。直接用于下一步反应。1H-NMR(300MHz,DMSO)δ1.37(t,3H),4.13(q,2H),6.40(s,1H),6.68(s,1H),7.44(s,1H),13.20(bs,1H)。ESI-MS(m/z)227(M+1)。3-Acetamido-4-ethoxy-6-nitrobenzoic acid methyl ester (85.0g, 0.3mol) was dissolved in THF (500mL) and 10% aqueous sodium hydroxide solution (500mL, 1.3mol), reflux reaction 4h, the reaction ended. Cool to room temperature, the reaction solution is layered, the upper layer is light yellow, the lower layer is dark brown, separate the layers, adjust the pH value of the lower layer to 4-5 with glacial acetic acid, extract with ethyl acetate (200mL×5 times), wash the organic layer with water, and dry , the solvent was distilled off to obtain 63.8 g of methyl 3-amino-4-ethoxy-6-nitrobenzoate as a brown blocky solid, with a yield of 94%. used directly in the next reaction. 1 H-NMR (300MHz, DMSO) δ1.37(t, 3H), 4.13(q, 2H), 6.40(s, 1H), 6.68(s, 1H), 7.44(s, 1H), 13.20(bs, 1H). ESI-MS (m/z) 227 (M+1).

将3-胺基-4-乙氧基-6-硝基苯甲酸甲酯(63.8g,0.282mol)溶于冰乙酸(600mL)中,60℃搅拌,滴加乙酸酐(29.0mL,0.3mol),1h加完,反应结束。将反应液倒入冰水(1000mL)中,析出大量灰色粉末,放置1h,抽滤,水洗,干燥,得灰黄色固体的3-乙酰胺基-4-乙氧基-6-硝基苯甲酸63.0g,,收率83%。1H-NMR(300MHz,DMSO)δ1.40(t,3H),2.17(s,3H),4.26(q,2H),7.60(s,1H),8.56(s,1H),9.46(s,1H),13.50(bs,1H)。。ESI-MS(m/z)267(M-1)。Dissolve methyl 3-amino-4-ethoxy-6-nitrobenzoate (63.8g, 0.282mol) in glacial acetic acid (600mL), stir at 60°C, add dropwise acetic anhydride (29.0mL, 0.3mol ), 1h added, the reaction ended. The reaction solution was poured into ice water (1000mL), a large amount of gray powder was precipitated, left for 1h, suction filtered, washed with water, and dried to obtain 3-acetamido-4-ethoxy-6-nitrobenzoic acid as a pale yellow solid 63.0 g, yield 83%. 1 H-NMR (300MHz, DMSO) δ1.40(t, 3H), 2.17(s, 3H), 4.26(q, 2H), 7.60(s, 1H), 8.56(s, 1H), 9.46(s, 1H), 13.50 (bs, 1H). . ESI-MS (m/z) 267 (M-1).

将3-乙酰胺基-4-乙氧基-6-硝基苯甲酸(54.0g,0.2mol)溶于二氯甲烷(300ml)中,未全溶,加入氯化亚砜(58.0ml,0.8mol),回流反应,冷凝管上端放置无水氯化钙干燥管,2h后反应结束,反应液澄清。浓缩得到褐色固体的3-乙酰胺基-4-乙氧基-6-硝基苯甲酰氯。Dissolve 3-acetamido-4-ethoxy-6-nitrobenzoic acid (54.0g, 0.2mol) in dichloromethane (300ml), and add thionyl chloride (58.0ml, 0.8 mol), reflux reaction, anhydrous calcium chloride drying tube is placed on the upper end of the condenser tube, the reaction ends after 2h, and the reaction solution is clarified. Concentration afforded 3-acetamido-4-ethoxy-6-nitrobenzoyl chloride as a brown solid.

将金属钠(9.2g,0.4mol)溶于乙醇(150ml),待钠全溶后再回流反应10min,待反应液冷却至50℃-60℃,滴加氰基乙酸乙酯(47.0ml,0.44mol),10min加完,反应液中生成大量白色粉末,再回流反应30min,而后冰盐浴冷却至-8℃。向反应液中滴加3-乙酰胺基-4-乙氧基-6-硝基苯甲酰氯的无水THF溶液(150ml),1h加完,保持反应温度0℃以下,滴加完毕反应即结束。向反应液中滴加冰水(100ml),保持反应液温度在10℃以下,再向反应液中加入浓硫酸(10ml,0.15mol)的冰水(1000ml)溶液,调反应液pH值为1-2,析出大量固体,搅拌放置1h,抽滤,洗涤,干燥得黄褐色固体的3-(5-乙酰胺基-4-乙氧基-2-硝基苯基)-2-氰基-3-羰基-丙酸乙酯(化合物V,R1=乙酰基,R2=乙基,R4=乙基,X=氰基,Z=-NH-)68.0g,收率93.5%。1HNMR(300MHz,DMSO)δ0.96(t,3H),1.43(t,3H),2.20(s,3H),3.86(q,2H),4.28(q,2H),7.79(s,1H),8.14(s,1H),9.51(s,1H)。ESI-Ms(m/z)362(M-1)。Sodium metal (9.2g, 0.4mol) was dissolved in ethanol (150ml), and after the sodium was completely dissolved, it was refluxed for 10 minutes. After the reaction solution was cooled to 50°C-60°C, ethyl cyanoacetate (47.0ml, 0.44 mol), after 10 minutes, a large amount of white powder was formed in the reaction solution, and then refluxed for 30 minutes, and then cooled to -8°C in an ice-salt bath. Add dropwise anhydrous THF solution (150ml) of 3-acetamido-4-ethoxy-6-nitrobenzoyl chloride to the reaction liquid, and finish adding after 1h, keeping the reaction temperature below 0°C, and the reaction is complete after the dropwise addition Finish. Add ice water (100ml) dropwise to the reaction solution, keep the temperature of the reaction solution below 10°C, then add a solution of concentrated sulfuric acid (10ml, 0.15mol) in ice water (1000ml) to the reaction solution, adjust the pH value of the reaction solution to 1 -2, a large amount of solids were precipitated, stirred for 1 hour, suction filtered, washed, and dried to obtain 3-(5-acetamido-4-ethoxy-2-nitrophenyl)-2-cyano- 3-Carbonyl-propionic acid ethyl ester (compound V, R 1 = acetyl, R 2 = ethyl, R 4 = ethyl, X = cyano, Z = -NH-) 68.0 g, yield 93.5%. 1 HNMR (300MHz, DMSO) δ0.96(t, 3H), 1.43(t, 3H), 2.20(s, 3H), 3.86(q, 2H), 4.28(q, 2H), 7.79(s, 1H) , 8.14(s, 1H), 9.51(s, 1H). ESI-Ms (m/z) 362 (M-1).

实施例十六3’-乙酰胺基-4’-乙氧基-6’-硝基-2-氰基苯乙酮(化合物I,R1=乙酰基,R2=乙基,X=氰基,Z=-NH-)的合成Example 16 3'-acetamido-4'-ethoxy-6'-nitro-2-cyanoacetophenone (compound I, R 1 = acetyl, R 2 = ethyl, X = cyano base, Z=-NH-) synthesis

将化合物V(R1=乙酰基,R2=乙基,R4=乙基,X=氰基,Z=-NH-)(36.3g,0.1mol)溶于96% DMSO/水(160ml),于110℃反应30min。反应液冷却后用水(800ml)稀释,析出黄色粉末,用1N硫酸调溶液pH为1-2,抽滤,水洗,干燥,得到淡黄色固体的3’-乙酰胺基-4’-乙氧基-6’-硝基-2-氰基苯乙酮(化合物I,R1=乙酰基,R2=乙基,X=氰基,Z=-NH-)25.8g,收率88.6%。1HNMR(300MHz,CDCl3)δ1.56(t,3H),2.28(s,3H),3.85(s,2H),4.28(q,2H),7.64(s,1H),8.02(s,1H),8.58(s,1H)。Compound V (R 1 = acetyl, R 2 = ethyl, R 4 = ethyl, X = cyano, Z = -NH-) (36.3 g, 0.1 mol) was dissolved in 96% DMSO/water (160 ml) , reacted at 110°C for 30min. After the reaction solution was cooled, it was diluted with water (800ml), and a yellow powder was precipitated. The pH of the solution was adjusted to 1-2 with 1N sulfuric acid, filtered with suction, washed with water, and dried to obtain 3'-acetamido-4'-ethoxy -6'-nitro-2-cyanoacetophenone (compound I, R 1 = acetyl, R 2 = ethyl, X = cyano, Z = -NH-) 25.8 g, yield 88.6%. 1 HNMR (300MHz, CDCl 3 ) δ1.56(t, 3H), 2.28(s, 3H), 3.85(s, 2H), 4.28(q, 2H), 7.64(s, 1H), 8.02(s, 1H ), 8.58(s, 1H).

实施例十七 3’-苯甲酰胺基-4’-乙氧基-6’-硝基-2-氰基苯乙酮(化合物I,R1=苯甲酰基,R2=乙基,X=氰基,Z=-NH-)的合成Example 17 3'-benzamido-4'-ethoxy-6'-nitro-2-cyanoacetophenone (compound I, R 1 = benzoyl, R 2 = ethyl, X = cyano group, Z = -NH-) synthesis

以3-氨基-4-羟基苯乙酮为原料,按照实施例一的步骤3、4以及实施例二至四的操作,经苯甲酰化、乙基化、硝化、溴代、氰基化制备标题化合物,得黄色粉末的标题化合物3’-苯甲酰胺基-4’-乙氧基-6’-硝基-2-氰基苯乙酮(化合物I,R1=苯甲酰基,R2=乙基,X=氰基,Z=-NH-),总收率56%。ESI-MS(m/z)352(M-1)。Using 3-amino-4-hydroxyacetophenone as a raw material, according to the steps 3 and 4 of Example 1 and the operations of Examples 2 to 4, through benzoylation, ethylation, nitration, bromination, and cyanation The title compound was prepared to give the title compound 3'-benzamido-4'-ethoxy-6'-nitro-2-cyanoacetophenone (compound I, R 1 =benzoyl, R 2 = ethyl, X = cyano, Z = -NH-), the total yield was 56%. ESI-MS (m/z) 352 (M-1).

实施例十八 3’-苄胺基-4’-乙氧基-6’-硝基-2-氰基苯乙酮(化合物I,R1=苄基,R2=乙基,X=氰基,Z=-NH-)的合成Example 18 3'-benzylamino-4'-ethoxy-6'-nitro-2-cyanoacetophenone (Compound I, R 1 = benzyl, R 2 = ethyl, X = cyano base, Z=-NH-) synthesis

以3-苄胺基-4-乙氧基苯乙酮为原料,按照实施例二至四的操作,同法制备标题化合物,得黄色粉末的标题化合物3’-苄胺基-4’-乙氧基-6’-硝基-2-氰基苯乙酮(化合物I,R1=苄基,R2=乙基,X=氰基,Z=-NH-)。ESI-MS(m/z)338(M-1)。Using 3-benzylamino-4-ethoxyacetophenone as raw material, according to the operation of Examples 2 to 4, the title compound was prepared in the same way to obtain the title compound 3'-benzylamino-4'-B as a yellow powder Oxy-6'-nitro-2-cyanoacetophenone (Compound I, R 1 =benzyl, R 2 =ethyl, X=cyano, Z=-NH-). ESI-MS (m/z) 338 (M-1).

实施例十九3’-乙酰胺基-4’-乙氧基-6’-氨基-2-氰基苯乙酮(化合物VIII,R1=乙酰基,R2=乙基,X=氰基,Z=-NH-)的合成Example 19 3'-acetamido-4'-ethoxy-6'-amino-2-cyanoacetophenone (compound VIII, R 1 = acetyl, R 2 = ethyl, X = cyano , Z=-NH-) synthesis

化合物I(R1=乙酰基,R2=乙基,X=氰基,Z=-NH-)(29.1g,0.1mol)、铁粉(28g,0.5mol)与400ml四氢呋喃、50ml乙醇、20ml水混合,加稀盐酸调pH=4-5,回流2h,反应结束。过滤,蒸干溶剂得褐色固体,用四氢呋喃/乙酸乙酯(1∶1,200ml)打浆得灰黄色固体的化合物VIII(R1=乙酰基,R2=乙基,X=氰基,Z=-NH-)21.5g,收率81%。1HNMR(300MHz,DMSO)δ1.36(t,3H),1.99(s,3H),3.27(s,2H),4.00(q,2H),6.33(s,1H),7.28(s,1H),7.76(s,1H),8.88(s,1H)。EI-MS(m/z)261(M+)。Compound I (R 1 = acetyl, R 2 = ethyl, X = cyano, Z = -NH-) (29.1g, 0.1mol), iron powder (28g, 0.5mol) and 400ml tetrahydrofuran, 50ml ethanol, 20ml Mix with water, add dilute hydrochloric acid to adjust pH=4-5, reflux for 2h, and the reaction is over. Filter and evaporate the solvent to obtain a brown solid, which was slurried with tetrahydrofuran/ethyl acetate (1:1, 200ml) to obtain compound VIII (R 1 = acetyl, R 2 = ethyl, X = cyano, Z = -NH-) 21.5g, yield 81%. 1 HNMR (300MHz, DMSO) δ1.36(t, 3H), 1.99(s, 3H), 3.27(s, 2H), 4.00(q, 2H), 6.33(s, 1H), 7.28(s, 1H) , 7.76(s, 1H), 8.88(s, 1H). EI-MS (m/z) 261 (M + ).

实施例二十 6-乙酰胺基-7-乙氧基-3-氰基-4-羟基喹啉(化合物A,R1=乙酰基,R2=乙基,X=氰基,Z=-NH-)的合成Example 20 6-acetamido-7-ethoxy-3-cyano-4-hydroxyquinoline (compound A, R 1 = acetyl, R 2 = ethyl, X = cyano, Z = - Synthesis of NH-)

室温,化合物VIII(R1=乙酰基,R2=乙基,X=氰基,Z=-NH-)(26.1g,0.1mol)溶于乙二醇二甲醚(250mL),加入N,N-二甲酰胺二甲缩醛(DMF-DMA)(16.0ml,0.12mol),反应4h,反应液中析出灰黄色粉末,抽滤,洗涤,干燥得灰黄色固体6-乙酰胺基-7-乙氧基-3-氰基-4-羟基喹啉(化合物A,R1=乙酰基,R2=乙基,X=氰基,Z=-NH-)22.5g,收率83.0%。1HNMR(300MHz,DMSO)δ1.45(t,3H),2.14(s,3H),4.20(q,2H),7.05(s,1H),8.60(s,1H),8.70(s,1H),9.21(s,1H),12.58(s,1H)。ESI-Ms(m/z)270(M-1)。At room temperature, compound VIII (R 1 = acetyl, R 2 = ethyl, X = cyano, Z = -NH-) (26.1 g, 0.1 mol) was dissolved in ethylene glycol dimethyl ether (250 mL), N was added, N-diformamide dimethyl acetal (DMF-DMA) (16.0ml, 0.12mol), reacted for 4h, gray-yellow powder precipitated in the reaction solution, suction filtered, washed, dried to give gray-yellow solid 6-acetamido-7 - Ethoxy-3-cyano-4-hydroxyquinoline (compound A, R 1 = acetyl, R 2 = ethyl, X = cyano, Z = -NH-) 22.5 g, yield 83.0%. 1 HNMR (300MHz, DMSO) δ1.45(t, 3H), 2.14(s, 3H), 4.20(q, 2H), 7.05(s, 1H), 8.60(s, 1H), 8.70(s, 1H) , 9.21(s, 1H), 12.58(s, 1H). ESI-Ms (m/z) 270 (M-1).

实施例二十一 6-乙酰胺基-7-乙氧基-3-氰基-4-羟基喹啉(化合物A,R1=乙酰基,R2=乙基,X=氰基,Z=-NH-)的合成Example 21 6-acetamido-7-ethoxy-3-cyano-4-hydroxyquinoline (compound A, R 1 = acetyl, R 2 = ethyl, X = cyano, Z = -NH-) Synthesis

冰浴下,化合物VIII·HCl(即VIII的盐酸盐,R1=乙酰基,R2=乙基,X =氰基,Z=-NH-)(29.7g,0.1mol)与乙二醇二甲醚混合,冰浴,滴加N,N-二甲酰胺二甲缩醛(DMF-DMA)(13.3ml,0.1mol),反应4h,反应结束。将反应液浓缩至一半体积,滤液倒入碎冰(100g)中,放置1h,析出土黄色固体,抽滤,水洗,干燥得土黄色固体6-乙酰胺基-7-乙氧基-3-氰基-4-羟基喹啉(化合物A,R1=乙酰基,R2=乙基,X=氰基,Z=-NH-)23.5g,收率80%。1HNMR(300MHz,DMSO)δ1.45(t,3H),2.14(s,3H),4.20(q,2H),7.05(s,1H),8.60(s,1H),8.70(s,1H),9.21(s,1H),12.58(s,1H)。ESI-Ms(m/z)270(M-1)。Under ice bath, compound VIII·HCl (the hydrochloride salt of VIII, R 1 = acetyl, R 2 = ethyl, X = cyano, Z = -NH-) (29.7 g, 0.1 mol) and ethylene glycol Dimethyl ether was mixed, ice bathed, N,N-dimethylamide dimethyl acetal (DMF-DMA) (13.3ml, 0.1mol) was added dropwise, reacted for 4h, and the reaction was completed. Concentrate the reaction solution to half its volume, pour the filtrate into crushed ice (100g), and let it stand for 1h. A khaki solid precipitates, which is filtered with suction, washed with water, and dried to obtain a khaki solid 6-acetamido-7-ethoxy-3- Cyano-4-hydroxyquinoline (compound A, R 1 = acetyl, R 2 = ethyl, X = cyano, Z = -NH-) 23.5 g, yield 80%. 1 HNMR (300MHz, DMSO) δ1.45(t, 3H), 2.14(s, 3H), 4.20(q, 2H), 7.05(s, 1H), 8.60(s, 1H), 8.70(s, 1H) , 9.21(s, 1H), 12.58(s, 1H). ESI-Ms (m/z) 270 (M-1).

实施例二十二 6-乙酰胺基-7-乙氧基-3-氰基-4-羟基喹啉(化合物A,R1=乙酰基,R2=乙基,X=氰基,Z=-NH-)的合成Example 22 6-acetamido-7-ethoxy-3-cyano-4-hydroxyquinoline (compound A, R 1 = acetyl, R 2 = ethyl, X = cyano, Z = -NH-) Synthesis

化合物VIII(R1=乙酰基,R2=乙基,X=氰基,Z=-NH-)(26.1g,0.1mol)悬浮于乙二醇二甲醚(250ml),加入原甲酸三乙酯(20.0ml,0.12mol),回流反应3h,反应结束。反应液中析出土黄色粉末,抽滤,洗涤,干燥得土黄色固体的6-乙酰胺基-7-乙氧基-3-氰基-4-羟基喹啉(化合物A,R1=乙酰基,R2=乙基,X=氰基,Z=-NH-)20.5g,收率76%。1HNMR(300MHz,DMSO)δ1.45(t,3H),2.14(s,3H),4.20(q,2H),7.05(s,1H),8.60(s,1H),8.70(s,1H),9.21(s,1H),12.58(s,1H)。ESI-Ms(m/z)270(M-1)。Compound VIII (R 1 = acetyl, R 2 = ethyl, X = cyano, Z = -NH-) (26.1 g, 0.1 mol) was suspended in ethylene glycol dimethyl ether (250 ml), and triethyl orthoformate was added Ester (20.0ml, 0.12mol) was refluxed for 3h, and the reaction was completed. A khaki powder was precipitated in the reaction solution, filtered by suction, washed, and dried to obtain 6-acetamido-7-ethoxy-3-cyano-4-hydroxyquinoline (compound A, R 1 =acetyl , R 2 = ethyl, X = cyano, Z = -NH-) 20.5 g, yield 76%. 1 HNMR (300MHz, DMSO) δ1.45(t, 3H), 2.14(s, 3H), 4.20(q, 2H), 7.05(s, 1H), 8.60(s, 1H), 8.70(s, 1H) , 9.21(s, 1H), 12.58(s, 1H). ESI-Ms (m/z) 270 (M-1).

实施例二十三2-(5-乙酰氨基-4-乙氧基-2-硝基苯甲酰基)丙二酸二乙酯(化合物V,R1=乙基,R2=乙基,X=乙氧基羰基,R4=乙基,Z=-NH-)的合成Example 23 Diethyl 2-(5-acetylamino-4-ethoxy-2-nitrobenzoyl)malonate (compound V, R 1 = ethyl, R 2 = ethyl, X = ethoxycarbonyl, R 4 = ethyl, Z = -NH-) synthesis

常温下,将3-乙酰胺基-4-乙氧基-6-硝基苯甲酸(5.3g,0.02mol)悬浮于二氯甲烷(60ml)中,加入氯化亚砜(7.2ml,0.1mol),回流反应,1h后反应结束,反应液澄清。蒸干溶剂得褐色固体,加入无水THF溶液(30ml),蒸干,得3-乙酰胺基-4-乙氧基-6-硝基苯甲酰氯,可直接用于下一步反应。At room temperature, 3-acetamido-4-ethoxy-6-nitrobenzoic acid (5.3g, 0.02mol) was suspended in dichloromethane (60ml), and thionyl chloride (7.2ml, 0.1mol ), reflux reaction, the reaction ended after 1h, and the reaction solution was clarified. The solvent was evaporated to dryness to obtain a brown solid, which was added with anhydrous THF solution (30ml) and evaporated to dryness to obtain 3-acetamido-4-ethoxy-6-nitrobenzoyl chloride, which could be directly used in the next reaction.

常温下,将金属钠(1.0g,0.043mol)溶于乙醇(30ml),待钠全溶后再回流反应10min,待反应液冷却至50℃-60℃,滴加丙二酸二乙酯(7.0ml,0.046mol),3min加完,再回流反应30min,溶液澄清,而后冷却至-10℃。向反应液中滴加3-乙酰胺基-4-乙氧基-6-硝基苯甲酰氯的无水THF溶液(30ml),20min加完,保持反应温度0℃以下,滴加完毕反应即结束。向反应液中滴加冰水(20ml),保持反应液温度在0℃以下,再用稀硫酸调反应液pH值为1-2,搅拌放置,析出固体,抽滤,洗涤,干燥得黄褐色固体的2-(5-乙酰氨基-4-乙氧基-2-硝基苯甲酰基)丙二酸二乙酯(化合物V,R1=乙基,R2=乙基,X=乙氧基羰基,R4=乙基,Z=-NH-)6.4g,收率78.0%。1H-NMR(300MHz,CDCl3)δ0.98(t,3H),1.36(t,3H),1.53(t,3H),2.23(s,3H),3.94(q,2H),4.24(q,2H),4.37(q,2H),7.67(s,1H),7.91(s,1H),8.53(s,1H),14.1(s,1H)。EI-MS(m/z)410(M+)。At room temperature, dissolve metal sodium (1.0g, 0.043mol) in ethanol (30ml), and then reflux for 10 minutes after the sodium is completely dissolved. After the reaction solution is cooled to 50°C-60°C, diethyl malonate ( 7.0ml, 0.046mol), the addition was completed in 3 minutes, and the reaction was refluxed for 30 minutes. The solution was clear, and then cooled to -10°C. Add dropwise anhydrous THF solution (30ml) of 3-acetamido-4-ethoxy-6-nitrobenzoyl chloride to the reaction solution, and finish adding in 20 minutes, keep the reaction temperature below 0°C, and the reaction is complete after the dropwise addition Finish. Add ice water (20ml) dropwise to the reaction solution, keep the temperature of the reaction solution below 0°C, then use dilute sulfuric acid to adjust the pH of the reaction solution to 1-2, stir and let it stand, precipitate solid, suction filter, wash, and dry to obtain yellowish brown Solid diethyl 2-(5-acetylamino-4-ethoxy-2-nitrobenzoyl)malonate (compound V, R 1 = ethyl, R 2 = ethyl, X = ethoxy Carbonyl, R 4 = ethyl, Z = -NH-) 6.4 g, yield 78.0%. 1 H-NMR (300MHz, CDCl 3 ) δ0.98(t, 3H), 1.36(t, 3H), 1.53(t, 3H), 2.23(s, 3H), 3.94(q, 2H), 4.24(q , 2H), 4.37(q, 2H), 7.67(s, 1H), 7.91(s, 1H), 8.53(s, 1H), 14.1(s, 1H). EI-MS (m/z) 410 (M + ).

实施例二十四 3’-乙酰胺基-4’-乙氧基-6’-硝基-2-乙氧基羰基苯乙酮(化合物I,R1=乙酰基,R2=乙基,X=乙氧基羰基,Z=-NH-)的合成Example 24 3'-acetamido-4'-ethoxy-6'-nitro-2-ethoxycarbonylacetophenone (compound I, R 1 = acetyl, R 2 = ethyl, Synthesis of X=ethoxycarbonyl, Z=-NH-)

将化合物V(R1=乙基,R2=乙基,X=乙氧基羰基,R4=乙基,Z=-NH-)(3.1g,0.0076mol)溶于90% DMSO/水(20ml),于110℃反应30min。反应液冷却后用水(150ml)稀释,析出黄色粉末,用稀硫酸调反应液pH值为2-3,搅拌放置,析出固体,抽滤,洗涤,干燥得淡黄色固体的化合物I(R1=乙酰基,R2=乙基,X=乙氧基羰基,Z=-NH-)2.3g,收率91.0%。1H-NMR(300MHz,CDCl3)δ1.25(t,3H),1.53(t,3H),2.25(s,3H),3.83(s,2H),4.17(q,2H),4.24(q,2H),7.59(s,1H),7.95(s,1H),8.59(s,1H)。EI-MS(m/z)338(M+)。Compound V (R 1 = ethyl, R 2 = ethyl, X = ethoxycarbonyl, R 4 = ethyl, Z = -NH-) (3.1 g, 0.0076 mol) was dissolved in 90% DMSO/water ( 20ml), react at 110°C for 30min. After the reaction solution was cooled, it was diluted with water (150ml), and a yellow powder was precipitated. The pH value of the reaction solution was adjusted to 2-3 with dilute sulfuric acid, stirred and placed, and a solid was precipitated, filtered by suction, washed, and dried to obtain compound I (R1=acetyl base, R2=ethyl, X=ethoxycarbonyl, Z=-NH-) 2.3 g, yield 91.0%. 1 H-NMR (300MHz, CDCl 3 ) δ1.25(t, 3H), 1.53(t, 3H), 2.25(s, 3H), 3.83(s, 2H), 4.17(q, 2H), 4.24(q , 2H), 7.59(s, 1H), 7.95(s, 1H), 8.59(s, 1H). EI-MS (m/z) 338 (M + ).

实施例二十五 N-(5-(2-乙氧基羰基-3-(二甲基胺基)丙烯酰基)-2-乙氧基-4-硝基苯基)乙酰胺(化合物VI,R1=乙酰基,R2=乙基,X=乙氧基羰基,Y=-N(CH3)2,Z=-NH-)的合成Example 25 N-(5-(2-ethoxycarbonyl-3-(dimethylamino)acryloyl)-2-ethoxy-4-nitrophenyl)acetamide (compound VI, Synthesis of R 1 = acetyl, R 2 = ethyl, X = ethoxycarbonyl, Y = -N(CH 3 ) 2 , Z = -NH-)

将化合物I(R1=乙酰基,R2=乙基,X=乙氧基羰基,Z=-NH-)(0.8g,0.00236mol)溶于乙二醇二甲醚(20ml),加入N,N-二甲酰胺二甲缩醛(DMF-DMA)(0.93ml,0.007mol),回流反应6-8h,反应结束。蒸干溶剂得淡黄色固体化合物VI(R1=乙酰基,R2=乙基,X=乙氧基羰基,Y=-N(CH3)2,Z=-NH-)0.95g,可直接用于下一步反应。1H-NMR(300MHz,CDCl3)δ0.91(t,3H),1.45(t,3H),2.17(s,3H),3.04(s,3H),3.32(s,3H),3.87(q,2H),4.16(q,2H),7.53(s,1H),7.92(s,1H),7.98(s,1H),9.39(s,1H)。EI-MS(m/z)393(M+)。Compound I (R 1 = acetyl, R 2 = ethyl, X = ethoxycarbonyl, Z = -NH-) (0.8 g, 0.00236 mol) was dissolved in ethylene glycol dimethyl ether (20 ml), and N , N-diformamide dimethyl acetal (DMF-DMA) (0.93ml, 0.007mol), reflux reaction for 6-8h, the reaction ended. The solvent was evaporated to dryness to obtain 0.95 g of light yellow solid compound VI (R 1 = acetyl, R 2 = ethyl, X = ethoxycarbonyl, Y = -N(CH 3 ) 2 , Z = -NH-), which can be directly for the next reaction. 1 H-NMR (300MHz, CDCl 3 ) δ0.91(t, 3H), 1.45(t, 3H), 2.17(s, 3H), 3.04(s, 3H), 3.32(s, 3H), 3.87(q , 2H), 4.16 (q, 2H), 7.53 (s, 1H), 7.92 (s, 1H), 7.98 (s, 1H), 9.39 (s, 1H). EI-MS (m/z) 393 (M + ).

实施例二十六 化合物VIII(R1=乙酰基,R2=乙基,X=乙氧基羰基,Z=-NH-)的合成Example 26 Synthesis of Compound VIII (R 1 = Acetyl, R 2 = Ethyl, X = Ethoxycarbonyl, Z = -NH-)

将化合物I(R1=乙酰基,R2=乙基,X=乙氧基羰基,Z=-NH-)(0.8g,0.00236mol)溶于THF(20ml),加入Raney Ni(0.2g),室温氢化反应12h,反应结束。过滤,蒸干滤液得黄褐色固体的化合物VIII(R1=乙酰基,R2=乙基,X=乙氧羰基,Z=-NH-)0.67g,收率91.5%。1H-NMR(300MHz,CDCl3)δ1.22(t,3H),1.48(t,3H),2.20(s,3H),3.95(s,2H),4.18(q,2H),4.24(q,2H),6.05(s,1H),6.31(s,1H),7.45(s,1H),8.63(s,1H)。ESI-MS(m/z)331(M+23)。Compound I (R 1 = acetyl, R 2 = ethyl, X = ethoxycarbonyl, Z = -NH-) (0.8 g, 0.00236 mol) was dissolved in THF (20 ml), and Raney Ni (0.2 g) was added , hydrogenation reaction at room temperature for 12h, the reaction ended. After filtration, the filtrate was evaporated to dryness to obtain 0.67 g of compound VIII (R 1 = acetyl, R 2 = ethyl, X = ethoxycarbonyl, Z = -NH-) as a tan solid, with a yield of 91.5%. 1 H-NMR (300MHz, CDCl 3 ) δ1.22(t, 3H), 1.48(t, 3H), 2.20(s, 3H), 3.95(s, 2H), 4.18(q, 2H), 4.24(q , 2H), 6.05 (s, 1H), 6.31 (s, 1H), 7.45 (s, 1H), 8.63 (s, 1H). ESI-MS (m/z) 331 (M+23).

实施例二十七 6-乙酰胺基-7-乙氧基-3-氨基羰基-4-羟基喹啉(化合物A,R1=乙酰基,R2=乙基,X=乙氧基羰基,Z=-NH-)的合成Example 27 6-acetamido-7-ethoxy-3-aminocarbonyl-4-hydroxyquinoline (Compound A, R 1 =acetyl, R2 =ethyl, X =ethoxycarbonyl, Z =-NH-) Synthesis

将化合物VI(R1=乙酰基,R2=乙基,X=乙氧基羰基,Y=-N(CH3)2,Z=-NH-)(0.4g,1mmol)溶于DMF(3mL),加入RaneyNi 0.1g,常压氢化反应4h,反应结束。过滤,滤液浓缩至一半体积,再用水(4mL)稀释,析出白色固体,抽滤,水洗,干燥,得淡黄色粉末的6-乙酰胺基-7-乙氧基-3-氨基羰基-4-羟基喹啉(化合物A,R1=乙酰基,R2=乙基,X=乙氧基羰基,Z=-NH-)0.20g,收率62%。1H-NMR(300MHz,DMSO)δ1.26(t,3H),1.47(t,3H),2.18(s,3H),4.20(q,4H),7.07(s,1H),7.36(s,1H),8.68(s,1H),9.13(s,1H),12.04(s,1H)。EI-MS(m/z)318(M+)。Compound VI (R 1 = acetyl, R 2 = ethyl, X = ethoxycarbonyl, Y = -N(CH 3 ) 2 , Z = -NH-) (0.4 g, 1 mmol) was dissolved in DMF (3 mL ), adding RaneyNi 0.1g, atmospheric pressure hydrogenation reaction 4h, the reaction ended. Filtration, the filtrate was concentrated to half volume, and then diluted with water (4mL), a white solid was precipitated, filtered with suction, washed with water, and dried to obtain 6-acetamido-7-ethoxy-3-aminocarbonyl-4- Hydroxyquinoline (compound A, R 1 = acetyl, R 2 = ethyl, X = ethoxycarbonyl, Z = -NH-) 0.20 g, yield 62%. 1 H-NMR (300MHz, DMSO) δ1.26(t, 3H), 1.47(t, 3H), 2.18(s, 3H), 4.20(q, 4H), 7.07(s, 1H), 7.36(s, 1H), 8.68(s, 1H), 9.13(s, 1H), 12.04(s, 1H). EI-MS (m/z) 318 (M + ).

实施例二十八 6-乙酰胺基-7-乙氧基-3-氨基羰基-4-羟基喹啉(化合物A,R1=乙酰基,R2=乙基,X=乙氧基羰基,Z=-NH-)的合成Example 28 6-acetamido-7-ethoxy-3-aminocarbonyl-4-hydroxyquinoline (compound A, R 1 = acetyl, R 2 = ethyl, X = ethoxycarbonyl, Synthesis of Z=-NH-)

常温,化合物VIII(R1=乙酰基,R2=乙基,X=乙氧基羰基,Z=-NH-)(0.31g,1mmol)悬浮于乙二醇二甲醚(4mL),加入N,N-二甲酰胺二甲缩醛(DMF-DMA)(0.16mL,1.2mol),反应2h,反应液中析出土黄色粉末,抽滤,洗涤,干燥得土黄色固体6-乙酰胺基-7-乙氧基-3-氰基-4-羟基喹啉(化合物A,R1=乙酰基,R2=乙基,X=乙氧基羰基,Z=-NH-)0.22g,收率69%。At room temperature, compound VIII (R 1 = acetyl, R 2 = ethyl, X = ethoxycarbonyl, Z = -NH-) (0.31 g, 1 mmol) was suspended in ethylene glycol dimethyl ether (4 mL), and N , N-diformamide dimethyl acetal (DMF-DMA) (0.16mL, 1.2mol), reacted for 2h, a khaki powder was precipitated in the reaction solution, suction filtered, washed, and dried to obtain a khaki solid 6-acetamido- 7-ethoxy-3-cyano-4-hydroxyquinoline (compound A, R 1 = acetyl, R 2 = ethyl, X = ethoxycarbonyl, Z = -NH-) 0.22 g, yield 69%.

实施例二十九 6-乙酰胺基-7-乙氧基-3-氰基-4-氯喹啉(化合物A’,R1=乙酰基,R2=乙基,X=氰基,Z=-NH-)的合成Example 29 6-acetamido-7-ethoxy-3-cyano-4-chloroquinoline (compound A', R 1 = acetyl, R 2 = ethyl, X = cyano, Z = -NH-) Synthesis

将化合物VI(R1=乙酰基,R2=乙基,X=氰基,Y=N(CH3)2,Z=-NH-)(15.5g,0.045mol)溶于DMF(130ml),加入Raney Ni 6g,常压氢化反应5~6h,TLC检测反应结束。过滤,滤液浓缩至干,所得产物再用二乙二醇二甲醚(120ml)溶解,加入三氯氧磷(9.3ml,0.099mol),于80℃(外温)下反应。4hr至4.5hr反应完毕,将反应液缓慢倒入2体积冰水中并搅拌1h,析出黄色粉末,抽滤,水洗,再用少量乙二醇二甲醚洗涤,40℃下干燥,得黄色粉末的化合物A’(R1=乙酰基,R2=乙基,X=乙氧基羰基,Z=-NH-)9.12g,收率70.6%。1HNMR(300MHz,DMSO)δ1.49(t,3H),2.25(s,3H),4.38(q,2H),7.58(s,1H),8.98(s,1H),9.09(s,1H),9.51(s,1H)。ESI-Ms(m/z)289(M-1)。Compound VI (R 1 = acetyl, R 2 = ethyl, X = cyano, Y = N(CH 3 ) 2 , Z = -NH-) (15.5 g, 0.045 mol) was dissolved in DMF (130 ml), Add 6g of Raney Ni, hydrogenation reaction at atmospheric pressure for 5-6h, TLC detection of the end of the reaction. After filtration, the filtrate was concentrated to dryness, and the obtained product was dissolved in diethylene glycol dimethyl ether (120ml), and phosphorus oxychloride (9.3ml, 0.099mol) was added to react at 80°C (external temperature). After 4hr to 4.5hr, the reaction is completed. Slowly pour the reaction solution into 2 volumes of ice water and stir for 1 hour. A yellow powder precipitates. Suction filtration, washing with water, washing with a small amount of ethylene glycol dimethyl ether, and drying at 40°C gives a yellow powder. Compound A' (R 1 = acetyl, R 2 = ethyl, X = ethoxycarbonyl, Z = -NH-) 9.12 g, yield 70.6%. 1 HNMR (300MHz, DMSO) δ1.49(t, 3H), 2.25(s, 3H), 4.38(q, 2H), 7.58(s, 1H), 8.98(s, 1H), 9.09(s, 1H) , 9.51 (s, 1H). ESI-Ms (m/z) 289 (M-1).

实施例三十 6-乙酰胺基-7-乙氧基-3-氰基-4-氯喹啉(化合物A’,R1=乙酰基,R2=乙基,X=氰基,Z=-NH-)的合成Example 30 6-acetamido-7-ethoxy-3-cyano-4-chloroquinoline (compound A', R 1 = acetyl, R 2 = ethyl, X = cyano, Z = - Synthesis of NH-)

化合物VIII(R1=乙酰基,R2=乙基,X=氰基,Z=-NH-)(11.75g,0.045mol)悬浮于乙二醇二甲醚(250ml),加入原甲酸三乙酯(20.0ml,0.12mol),回流反应3h,反应结束。冷至室温,再加入三氯氧磷(11ml),于80℃(外温)下反应。4hr至4.5hr反应完毕,将反应液缓慢倒入2体积冰水中并搅拌1h,析出黄色粉末,抽滤,水洗,再用少量乙二醇二甲醚洗涤,40℃下干燥,得黄色粉末的化合物A’(R1=乙酰基,R2=乙基,X=乙氧基羰基,Z=-NH-)8.9g,收率68.5%。1HNMR(300MHz,DMSO)δ1.49(t,3H),2.25(s,3H),4.38(q,2H),7.58(s,1H),8.98(s,1H),9.09(s,1H),9.51(s,1H)。ESI-Ms(m/z)289(M-1)。Compound VIII (R 1 = acetyl, R 2 = ethyl, X = cyano, Z = -NH-) (11.75 g, 0.045 mol) was suspended in ethylene glycol dimethyl ether (250 ml), and triethyl orthoformate was added Ester (20.0ml, 0.12mol) was refluxed for 3h, and the reaction was completed. After cooling to room temperature, phosphorus oxychloride (11 ml) was added and reacted at 80°C (external temperature). After 4hr to 4.5hr, the reaction is completed. Slowly pour the reaction solution into 2 volumes of ice water and stir for 1 hour. A yellow powder precipitates. Suction filtration, washing with water, washing with a small amount of ethylene glycol dimethyl ether, and drying at 40°C gives a yellow powder. Compound A' (R 1 = acetyl, R 2 = ethyl, X = ethoxycarbonyl, Z = -NH-) 8.9 g, yield 68.5%. 1 HNMR (300MHz, DMSO) δ1.49(t, 3H), 2.25(s, 3H), 4.38(q, 2H), 7.58(s, 1H), 8.98(s, 1H), 9.09(s, 1H) , 9.51 (s, 1H). ESI-Ms (m/z) 289 (M-1).

实施例三十一 3’-乙酰胺基-4’-乙氧基-6’-氨基-2-氰基苯乙酮(化合物X,R1=乙酰基,R2=乙基,X=氰基,R8=叔丁氧羰基,Z=-NH-)的合成Example 31 3'-acetamido-4'-ethoxy-6'-amino-2-cyanoacetophenone (compound X, R 1 = acetyl, R 2 = ethyl, X = cyano group, R 8 = tert-butoxycarbonyl, Z = -NH-) synthesis

将实施例十九的标题化合物(1g,0.0038mol)溶于12mL吡啶,室温下加入(BOC)2O(0.83mL,0.0046mol,)。室温反应12hr,反应液加20mL水,用二氯甲烷萃取3次(10mL/次),合并有机相,有机相用无水硫酸钠干燥,后蒸干溶剂,得淡黄色固体1.10g,收率80%。The title compound of Example 19 (1 g, 0.0038 mol) was dissolved in 12 mL of pyridine, and (BOC) 2 O (0.83 mL, 0.0046 mol,) was added at room temperature. React at room temperature for 12 hours, add 20 mL of water to the reaction solution, extract 3 times with dichloromethane (10 mL/time), combine the organic phases, dry the organic phases with anhydrous sodium sulfate, and evaporate the solvent to obtain 1.10 g of a light yellow solid. 80%.

实施例三十二 6-乙酰胺基-7-乙氧基-3-氰基-4-羟基喹啉(化合物A,R1=乙酰基,R2=乙基,X=氰基,Z=-NH-)的合成Example 32 6-acetamido-7-ethoxy-3-cyano-4-hydroxyquinoline (compound A, R 1 = acetyl, R 2 = ethyl, X = cyano, Z = -NH-) Synthesis

冰浴下,化合物X(R1=乙酰基,R2=乙基,X=氰基,R8=叔丁氧羰基,Z=-NH-)(0.1mol)溶于乙二醇二甲醚(250mL),加入N,N-二甲酰胺二甲缩醛(DMF-DMA)(16.0ml,0.12mol),反应5h,加入对甲苯磺酸(0.1mol),反应液中析出土黄色粉末,抽滤,洗涤,干燥得土黄色固体6-乙酰胺基-7-乙氧基-3-氰基-4-羟基喹啉(化合物A,R1=乙酰基,R2=乙基,X=氰基,Z=-NH-)22.5g,收率83.0%。1HNMR(300MHz,DMSO)δ1.45(t,3H),2.14(s,3H),4.20(q,2H),7.05(s,1H),8.60(s,1H),8.70(s,1H),9.21(s,1H),12.58(s,1H)。ESI-Ms(m/z)270(M-1)。Compound X (R 1 = acetyl, R 2 = ethyl, X = cyano, R 8 = tert-butoxycarbonyl, Z = -NH-) (0.1 mol) was dissolved in ethylene glycol dimethyl ether under ice bath (250mL), add N,N-diformamide dimethyl acetal (DMF-DMA) (16.0ml, 0.12mol), react for 5h, add p-toluenesulfonic acid (0.1mol), the reaction solution precipitates khaki powder, Suction filtration, washing, and drying to obtain khaki solid 6-acetamido-7-ethoxy-3-cyano-4-hydroxyquinoline (Compound A, R 1 =acetyl, R 2 =ethyl, X = Cyano, Z=-NH-) 22.5g, yield 83.0%. 1 HNMR (300MHz, DMSO) δ1.45(t, 3H), 2.14(s, 3H), 4.20(q, 2H), 7.05(s, 1H), 8.60(s, 1H), 8.70(s, 1H) , 9.21(s, 1H), 12.58(s, 1H). ESI-Ms (m/z) 270 (M-1).

实施例三十三 6-苯甲酰胺基-7-乙氧基-3-氰基-4-羟基喹啉(化合物A,R1=苯甲酰基,R2=乙基,X=氰基,Z=-NH-)的合成Example 33 6-benzamido-7-ethoxy-3-cyano-4-hydroxyquinoline (Compound A, R 1 =benzoyl, R 2 =ethyl, X = cyano, Synthesis of Z=-NH-)

以实施例十七的标题化合物为原料,按照实施例19~20的操作,同法制备实施例三十三的标题化合物,总收率71%。ESI-MS(m/z)332(M-1)。Using the title compound of Example 17 as a raw material, the title compound of Example 33 was prepared in the same way as in Examples 19-20, with a total yield of 71%. ESI-MS (m/z) 332 (M-1).

实施例三十四 6-苄胺基-7-乙氧基-3-氰基-4-羟基喹啉(化合物A,R1=苄基,R2=乙基,X=氰基,Z=-NH-)的合成Example 34 6-benzylamino-7-ethoxy-3-cyano-4-hydroxyquinoline (compound A, R 1 = benzyl, R 2 = ethyl, X = cyano, Z = -NH-) Synthesis

以实施例十八的标题化合物为原料,按照实施例19~20的操作,同法制备实施例三十四的标题化合物,得黄色固体,总收率69%。ESI-MS(m/z)318(M-1)。Using the title compound of Example 18 as a raw material, the title compound of Example 34 was prepared in the same way as in Examples 19-20 to obtain a yellow solid with a total yield of 69%. ESI-MS (m/z) 318 (M-1).

实施例三十五 3-甲氧基-4-(4-甲基-1-哌嗪基)丙氧基苯乙酮(化合物B,R1=甲基,R2=(4-甲基-1-哌嗪基)丙基,Z=-O-)的合成Example 35 3-Methoxy-4-(4-methyl-1-piperazinyl)propoxyacetophenone (compound B, R 1 =methyl, R 2 =(4-methyl- Synthesis of 1-piperazinyl)propyl, Z=-O-)

将3-甲氧基-4-(3-氯丙氧基)苯乙酮(化合物B,R1=甲基,R2=3-氯丙基,Z=-O-)(以3-甲氧基-4-羟基苯乙酮为原料按照文献制备(Journal ofMedicinal Chemistry,1989,32(1):105-118))与DMF、碳酸钾混合,60℃反应5小时,后处理同实施例一的步骤4,得实施例三十五的标题化合物。EI-MS(m/z)306(M+)。3-methoxy-4-(3-chloropropoxy)acetophenone (Compound B, R 1 =methyl, R 2 =3-chloropropyl, Z=-O-) (as 3-methyl Oxygen-4-hydroxyacetophenone was prepared according to the literature (Journal of Medicinal Chemistry, 1989, 32 (1): 105-118)), mixed with DMF and potassium carbonate, reacted at 60°C for 5 hours, and the post-treatment was the same as in Example 1. Step 4, the title compound of Example 35 was obtained. EI-MS (m/z) 306 (M + ).

实施例三十六 3’-甲氧基-4’-(4-甲基-1-哌嗪基)丙氧基-6’-硝基-2-氰基苯乙酮(化合物I,R1=甲基,R2=(4-甲基-1-嫩)丙基,X=氰基,Z=-O-)的合成Example 36 3'-methoxy-4'-(4-methyl-1-piperazinyl)propoxy-6'-nitro-2-cyanoacetophenone (Compound I, R 1 =methyl, R 2 =(4-methyl-1-enhen)propyl, X=cyano, Z=-O-) synthesis

参照实施例2到实施例4的合成操作,以实施例三十六的标题化合物为原料,同法制备实施例三十六的标题化合物,三步总收率69%。EI-MS(m/z)376(M+)。Referring to the synthesis operations of Examples 2 to 4, using the title compound of Example 36 as a raw material, the title compound of Example 36 was prepared in the same way, and the total yield of the three steps was 69%. EI-MS (m/z) 376 (M + ).

实施例三十七 3’-甲氧基-4’-(4-甲基-1-哌嗪基)丙氧基-6’-氨基-2-氰基苯乙酮(化合物VIII,R1=甲基,R2=(4-甲基-1-嫩)丙基,X=氰基,Z=-O-)的合成Example 37 3'-methoxy-4'-(4-methyl-1-piperazinyl)propoxy-6'-amino-2-cyanoacetophenone (compound VIII, R 1 = Synthesis of methyl group, R 2 =(4-methyl-1-enhenyl)propyl group, X=cyano group, Z=-O-)

化合物I(R1=甲基,R2=(4-甲基-1-哌嗪基)丙基,X=氰基,Z=-O-)采用铁粉还原,参照实施例十九的制备方法,得黄色固体的化合物VIII(R1=甲基,R2=(4-甲基-1-哌嗪基)丙基,X=氰基,Z=-O-),收率85%。EI-MS(m/z)346(M+)。Compound I (R 1 = methyl, R 2 = (4-methyl-1-piperazinyl) propyl, X = cyano, Z = -O-) was reduced with iron powder, referring to the preparation of Example 19 Method to obtain compound VIII (R 1 = methyl, R 2 = (4-methyl-1-piperazinyl) propyl, X = cyano, Z = -O-) as a yellow solid with a yield of 85%. EI-MS (m/z) 346 (M + ).

实施例三十八 6-甲氧基-7-(4-甲基-1-哌嗪基)丙氧基-3-氰基-4-羟基喹啉(化合物A,R1=甲基,R2=(4-甲基-1-哌嗪基)丙基,X=氰基,Z=-O-)的合成Example 38 6-methoxy-7-(4-methyl-1-piperazinyl)propoxy-3-cyano-4-hydroxyquinoline (compound A, R 1 =methyl, R 2 = (4-methyl-1-piperazinyl) propyl, X = cyano, Z = -O-) synthesis

冰浴下,化合物VIII(R1=甲基,R2=(4-甲基-1-哌嗪基)丙基,X=氰基,Z=-O-)(34.6g,0.1mol)悬浮于乙二醇二甲醚(250mL),加入N,N-二甲酰胺二甲缩醛(DMF-DMA)(16.0ml,0.12mol),反应4h,反应液中析出土黄色粉末,抽滤,洗涤,干燥得土黄色固体6-甲氧基-7-(4-甲基-1-哌嗪基)丙氧基-3-氰基-4-羟基喹啉(化合物A,R1=甲基,R2=(4-甲基-1-哌嗪基)丙基,X=氰基,Z=-O-)29.5g,收率82.8%。ESI-MS(m/z)357(M+1)。Compound VIII (R 1 = methyl, R 2 = (4-methyl-1-piperazinyl) propyl, X = cyano, Z = -O-) (34.6 g, 0.1 mol) was suspended under ice bath Add N,N-diformamide dimethyl acetal (DMF-DMA) (16.0ml, 0.12mol) to ethylene glycol dimethyl ether (250mL) and react for 4h. A khaki powder is precipitated in the reaction solution, which is suction filtered. Wash and dry to obtain khaki solid 6-methoxy-7-(4-methyl-1-piperazinyl)propoxy-3-cyano-4-hydroxyquinoline (compound A, R 1 =methyl , R 2 =(4-methyl-1-piperazinyl)propyl, X=cyano, Z=-O-) 29.5 g, yield 82.8%. ESI-MS (m/z) 357 (M+1).

实施例三十九 6-甲氧基-7-(4-甲基-1-哌嗪基)丙氧基-3-氰基-4-氯喹啉(化合物A’,R1=甲基,R2=(4-甲基-1-哌嗪基)丙基,X=氰基,Z=-O-)的合成Example 39 6-methoxy-7-(4-methyl-1-piperazinyl)propoxy-3-cyano-4-chloroquinoline (compound A', R 1 =methyl, R 2 = (4-methyl-1-piperazinyl) propyl, X = cyano, Z = -O-) synthesis

化合物VIII(R1=甲基,R2=(4-甲基-1-哌嗪基)丙基,X=氰基,Z=-O-)(15.6g,0.045mol)悬浮于乙二醇二甲醚(250ml),加入原甲酸三乙酯(20.0ml,0.12mol),回流反应3h,反应结束。冷至室温,再加入三氯氧磷(11ml),于80℃(外温)下反应。4hr至4.5hr反应完毕,将反应液缓慢倒入2体积冰水中并搅拌1h,析出黄色粉末,抽滤,水洗,再用少量乙二醇二甲醚洗涤,40℃下干燥,得黄色粉末的化合物A’(R1=甲基,R2=(4-甲基-1-哌嗪基)丙基,X=氰基,Z=-O-)11.5g,收率68%。EI-MS(m/z)376(M+)。Compound VIII (R 1 = methyl, R 2 = (4-methyl-1-piperazinyl) propyl, X = cyano, Z = -O-) (15.6 g, 0.045 mol) suspended in ethylene glycol Dimethyl ether (250ml), triethyl orthoformate (20.0ml, 0.12mol) was added, refluxed for 3h, and the reaction was completed. After cooling to room temperature, phosphorus oxychloride (11 ml) was added and reacted at 80°C (external temperature). After 4hr to 4.5hr, the reaction is completed. Slowly pour the reaction solution into 2 volumes of ice water and stir for 1 hour. A yellow powder is precipitated, filtered with suction, washed with water, washed with a small amount of ethylene glycol dimethyl ether, and dried at 40°C to obtain a yellow powder. Compound A' (R 1 =methyl, R 2 =(4-methyl-1-piperazinyl)propyl, X=cyano, Z=-O-) 11.5g, yield 68%. EI-MS (m/z) 376 (M + ).

实施例四十 6-乙酰胺基-7-乙氧基-3-氰基-4-羟基喹啉(化合物A,R1=乙酰基,R2=乙基,X=氰基,Z=-NH-)的合成Example 40 6-acetamido-7-ethoxy-3-cyano-4-hydroxyquinoline (compound A, R 1 = acetyl, R 2 = ethyl, X = cyano, Z = - Synthesis of NH-)

将化合物VI(R1=乙酰基,R2=乙基,X=氰基,Y=-N(CH3)2,Z=-NH-)(15g,0.0433mol)悬浮于乙醇(200mL)、水(200mL)和冰乙酸(4mL,0.065mol),加入锌粉(22g,0.35mol),100℃回流反应约12h,TLC检测反应完全后,略冷却,直接向反应液中加NaOH(0.13mol),反应液混浊。接着进行抽滤,而后进行如下步骤:Compound VI (R 1 = acetyl, R 2 = ethyl, X = cyano, Y = -N(CH 3 ) 2 , Z = -NH-) (15 g, 0.0433 mol) was suspended in ethanol (200 mL), Add water (200mL) and glacial acetic acid (4mL, 0.065mol), add zinc powder (22g, 0.35mol), reflux at 100°C for about 12h, after TLC detects that the reaction is complete, cool slightly, and directly add NaOH (0.13mol ), the reaction solution was turbid. Carry out suction filtration then, then carry out following steps:

将上述滤液在50-60℃调pH至3以下,析出产物。过滤,水洗,干燥,得标题化合物(酮式结构)10.1g,收率86%。1HNMR(300MHz,DMSO)δ1.45(t,3H),2.14(s,3H),4.20(q,2H),7.05(s,1H),8.60(d,1H),8.70(s,1H),9.21(s,1H),12.58(d,1H)。ESI-Ms(m/z)270(M-1)。Adjust the pH of the above filtrate to below 3 at 50-60°C to precipitate the product. Filter, wash with water, and dry to obtain 10.1 g of the title compound (ketone structure), with a yield of 86%. 1 HNMR (300MHz, DMSO) δ1.45(t, 3H), 2.14(s, 3H), 4.20(q, 2H), 7.05(s, 1H), 8.60(d, 1H), 8.70(s, 1H) , 9.21(s, 1H), 12.58(d, 1H). ESI-Ms (m/z) 270 (M-1).

或者,将上述滤液在50-60℃调pH至5-6,析出产物。过滤,水洗,干燥,得标题化合物(酚式结构)10.0g,收率85%。1HNMR(300MHz,DMSO)δ1.45(t,3H),2.14(s,3H),4.19(q,2H),7.15(s,1H),8.56(s,1H),8.69(s,1H),9.19(s,1H)。ESI-Ms(m/z)270(M-1)。Alternatively, adjust the pH of the above filtrate to 5-6 at 50-60° C. to precipitate the product. Filter, wash with water, and dry to obtain 10.0 g of the title compound (phenolic structure), with a yield of 85%. 1 HNMR (300MHz, DMSO) δ1.45(t, 3H), 2.14(s, 3H), 4.19(q, 2H), 7.15(s, 1H), 8.56(s, 1H), 8.69(s, 1H) , 9.19(s, 1H). ESI-Ms (m/z) 270 (M-1).

酮式结构          酚式结构Keto structure Phenolic structure

实施例四十一 6-乙酰胺基-7-乙氧基-3-氰基-4-羟基喹啉(化合物A,R1=乙酰基,R2=乙基,X=氰基,Z=-NH-)的合成Example 41 6-acetamido-7-ethoxy-3-cyano-4-hydroxyquinoline (compound A, R 1 = acetyl, R 2 = ethyl, X = cyano, Z = -NH-) Synthesis

将化合物VI(R1=乙酰基,R2=乙基,X=氰基,Y=-N(CH3)2,Z=-NH-)(15g,0.0433mol)悬浮于乙醇(300mL),再加入Fe粉(11g,0.18mol)、CaCl2(10g,0.0866mol),回流15h反应结束。略冷却,直接向反应液中加NaOH(0.13mol),反应液混浊,抽滤,上述滤液在50-60℃调pH至3以下,析出产物。过滤,水洗,干燥,得标题化合物6.7g,收率57%。Compound VI (R 1 =acetyl, R 2 =ethyl, X=cyano, Y=-N(CH 3 ) 2 , Z=-NH-) (15 g, 0.0433 mol) was suspended in ethanol (300 mL), Add Fe powder (11 g, 0.18 mol) and CaCl 2 (10 g, 0.0866 mol) and reflux for 15 h to complete the reaction. After slightly cooling, NaOH (0.13 mol) was directly added to the reaction solution, the reaction solution was turbid, filtered with suction, the pH of the above filtrate was adjusted to below 3 at 50-60°C, and the product was precipitated. Filter, wash with water, and dry to obtain 6.7 g of the title compound, with a yield of 57%.

实施例四十二 6-乙酰胺基-7-乙氧基-3-氰基-4-羟基喹啉(化合物A,R1=乙酰基,R2=乙基,X=氰基,Z=-NH-)的合成Example 42 6-acetamido-7-ethoxy-3-cyano-4-hydroxyquinoline (compound A, R 1 = acetyl, R 2 = ethyl, X = cyano, Z = -NH-) synthesis

将化合物VI(R1=乙酰基,R2=乙基,X=氰基,Y=-N(CH3)2,Z=-NH-)(15g,0.0433mol)悬浮于冰乙酸(300mL),再加入1g5%钯碳、室温常压通氢气反应,15h反应结束。反应液中逐渐析出固体。抽滤,水洗,干燥,得标题化合物7.1g,收率61%。Compound VI (R 1 =acetyl, R 2 =ethyl, X=cyano, Y=-N(CH 3 ) 2 , Z=-NH-) (15 g, 0.0433 mol) was suspended in glacial acetic acid (300 mL) , and then add 1g of 5% palladium carbon, and react with hydrogen gas at room temperature and pressure, and the reaction is completed in 15 hours. Solids gradually precipitated out of the reaction solution. Suction filtration, washing with water, and drying gave 7.1 g of the title compound with a yield of 61%.

Claims (14)

1.如下式I所示的6-硝基苯乙酮类化合物:1. 6-nitroacetophenone compounds shown in the following formula I: 其中,in, X为氰基、三氟甲基、C1~C10烷氧羰基或羧基;X is cyano, trifluoromethyl, C1-C10 alkoxycarbonyl or carboxyl; Z为-NH-或-O-;Z is -NH- or -O-; R1为C1~C5烷基、乙酰基、丙酰基、苯甲酰基、叔丁氧羰基、苄基、苄氧羰基或三苯甲基; R1 is C1~C5 alkyl, acetyl, propionyl, benzoyl, tert-butoxycarbonyl, benzyl, benzyloxycarbonyl or trityl; R2为甲基、乙基、丙基、苄基、-(CH2)n-Cl、-(CH2)n-Br、其中n为1~5的整数,Alkyl为C1~C5烷基。R 2 is methyl, ethyl, propyl, benzyl, -(CH 2 ) n -Cl, -(CH 2 ) n -Br, or Wherein n is an integer of 1-5, and Alkyl is a C1-C5 alkyl group. 2.根据权利要求1所述的式I所示的6-硝基苯乙酮类化合物,其中,2. the 6-nitroacetophenone compound shown in formula I according to claim 1, wherein, X为氰基、乙氧羰基或甲氧羰基;X is cyano, ethoxycarbonyl or methoxycarbonyl; Z为-NH-或-O-;Z is -NH- or -O-; R1为乙酰基、苯甲酰基、苄基或甲基; R is acetyl, benzoyl, benzyl or methyl; R2为乙基、-(CH2)3-Cl、-(CH2)3-Br、 R 2 is ethyl, -(CH 2 ) 3 -Cl, - (CH 2 ) 3 -Br, or 3.根据权利要求2所述的式I所示的6-硝基苯乙酮类化合物,其中,所述化合物为:3. the 6-nitroacetophenone compound shown in formula I according to claim 2, wherein, said compound is: 3’-乙酰胺基-4’-乙氧基-6’-硝基-2-氰基苯乙酮、3'-acetamido-4'-ethoxy-6'-nitro-2-cyanoacetophenone, 3’-苯甲酰胺基-4’-乙氧基-6’-硝基-2-氰基苯乙酮、3'-benzamido-4'-ethoxy-6'-nitro-2-cyanoacetophenone, 3’-苄胺基-4’-乙氧基-6’-硝基-2-氰基苯乙酮、3'-Benzylamino-4'-ethoxy-6'-nitro-2-cyanoacetophenone, 3’-乙酰胺基-4’-乙氧基-6’-硝基-2-乙氧基羰基苯乙酮、或3'-acetamido-4'-ethoxy-6'-nitro-2-ethoxycarbonylacetophenone, or 3’-甲氧基-4’-(4-甲基-1-哌嗪基)丙氧基-6’-硝基-2-氰基苯乙酮。3'-methoxy-4'-(4-methyl-1-piperazinyl)propoxy-6'-nitro-2-cyanoacetophenone. 4.权利要求1所述的式I所示的6-硝基苯乙酮类化合物的制备方法,其特征在于,X为氰基、三氟甲基、C1~C10烷氧羰基或羧基时,由化合物V经脱羧反应得到化合物I;其反应式为:4. the preparation method of the 6-nitroacetophenone compound shown in formula I described in claim 1, is characterized in that, when X is cyano group, trifluoromethyl, C1~C10 alkoxycarbonyl or carboxyl, Obtain compound I through decarboxylation reaction by compound V; Its reaction formula is: 其中R1、R2和Z的定义同权利要求1;R4为氢、C1~C10烷基或C1~C10链烯基。The definitions of R 1 , R 2 and Z are the same as in claim 1; R 4 is hydrogen, C1-C10 alkyl or C1-C10 alkenyl. 5.权利要求1所述的式I所示的6-硝基苯乙酮类化合物的制备方法,其特征在于,当X为氰基时,其制备方法为:5. the preparation method of the 6-nitroacetophenone compound shown in the formula I described in claim 1 is characterized in that, when X is cyano group, its preparation method is: (1)化合物B硝化得到化合物D,化合物D溴代得到化合物II,化合物II经氰基取代反应得到化合物I;其反应式为:(1) Compound B is nitrated to obtain compound D, compound D is brominated to obtain compound II, and compound II is subjected to cyano substitution reaction to obtain compound I; the reaction formula is: 其中R1、R2和Z的定义同权利要求1;或者wherein R 1 , R 2 and Z are as defined in claim 1; or (2)化合物B溴化得到化合物III,化合物III硝化得到化合物II,化合物II经氰基取代反应得到化合物I;其反应式为:(2) Compound B is brominated to obtain compound III, compound III is nitrated to obtain compound II, and compound II is subjected to a cyano substitution reaction to obtain compound I; the reaction formula is: 其中R1、R2和Z的定义同权利要求1;或者wherein R 1 , R 2 and Z are as defined in claim 1; or (3)化合物B溴代得到化合物III,化合物III经氰基取代反应得到化合物IV,化合物IV硝化得到化合物I;其反应式为:(3) Compound B is brominated to obtain Compound III, Compound III is subjected to a cyano substitution reaction to obtain Compound IV, and Compound IV is nitrated to obtain Compound I; the reaction formula is: 其中R1、R2和Z的定义同权利要求1。Wherein R 1 , R 2 and Z are as defined in claim 1. 6.权利要求1所述的式I所示的6-硝基苯乙酮类化合物在制备式A所示化合物中的用途,其中,按如下方法制备式A所示化合物,6. the purposes of the 6-nitroacetophenone compound shown in the formula I shown in claim 1 in the compound shown in the preparation formula A, wherein, prepare the compound shown in the formula A as follows, 其中R1、R2、Z和X的定义与权利要求1相同;Wherein the definitions of R 1 , R 2 , Z and X are the same as those in claim 1; (1)化合物I与化合物E进行缩合反应得到式VI所示化合物,(1) Condensation reaction of compound I and compound E to obtain the compound shown in formula VI, 其中,Y为-N(R5)2或-OR5,R5、R6和R7相同或不同地选自为C1~C10烷基或C1~C10链烯基中;Wherein, Y is -N(R 5 ) 2 or -OR 5 , and R 5 , R 6 and R 7 are identically or differently selected from C1~C10 alkyl or C1~C10 alkenyl; 化合物VI在还原条件下得到式VII所示化合物,式VII所示化合物环合得到式A所示化合物;或者化合物VII不经分离直接进行环合反应得到式A所示化合物;其反应式为:Compound VI obtains the compound shown in formula VII under reducing conditions, and the compound shown in formula VII is cyclized to obtain the compound shown in formula A; or the compound VII is directly subjected to cyclization reaction without separation to obtain the compound shown in formula A; its reaction formula is: 或者 or (2)化合物I在还原条件下得到化合物VIII或化合物VIII的酸加成盐,化合物VIII或其酸的加成盐与化合物E进行缩合反应得到化合物VII和/或化合物IX,化合物VII和/或化合物IX环合得到式A所示化合物;或者化合物VII和化合物IX不经分离直接进行环合反应得到式A所示化合物;其反应式为:(2) Compound I obtains Compound VIII or the acid addition salt of Compound VIII under reducing conditions, Compound VIII or its acid addition salt is condensed with Compound E to obtain Compound VII and/or Compound IX, Compound VII and/or Compound IX is cyclized to obtain a compound shown in Formula A; or Compound VII and Compound IX are directly subjected to a cyclization reaction without separation to obtain a compound shown in Formula A; the reaction formula is: or ;或者 ;or (3)化合物I在还原条件下得到化合物VIII,化合物VIII的苯氨基与酸酐(R8)2O或卤代物R8Cl、R8Br反应,得到化合物X,化合物X与化合物E进行缩合反应得到化合物XI,化合物XI经环合得到化合物XII,化合物XII脱R8保护基得到化合物A,其反应式为:(3) Compound I can obtain compound VIII under reducing conditions. The aniline of compound VIII reacts with acid anhydride (R 8 ) 2 O or halogenated products R 8 Cl, R 8 Br to obtain compound X, which undergoes condensation reaction with compound E Obtain compound XI, compound XI obtains compound XII through cyclization, compound XII removes R 8 protecting group obtains compound A, and its reaction formula is: 其中R8为甲酰基、C1~C10烷酰基或C1~C10烷氧基羰基;或者由化合物X制备化合物A的反应一锅完成,中间体XI和XII不经分离。Wherein R 8 is formyl, C1-C10 alkanoyl or C1-C10 alkoxycarbonyl; or the reaction of preparing compound A from compound X is completed in one pot, and intermediates XI and XII are not separated. 7.权利要求1所述的式I所示的6-硝基苯乙酮类化合物在制备式A’所示化合物中的用途,其中,按如下方法制备式A’所示化合物,7. the purposes of the 6-nitroacetophenone compound shown in the formula I shown in claim 1 in the compound shown in preparation formula A ', wherein, prepare the compound shown in formula A ' as follows, 其中R1、R2、Z和X的定义与权利要求1相同;Wherein the definitions of R 1 , R 2 , Z and X are the same as those in claim 1; (1)化合物I与化合物E进行缩合反应得到式VI所示化合物,(1) Condensation reaction of compound I and compound E to obtain the compound shown in formula VI, 其中,Y为-N(R5)2或-OR5,R5、R6和R7相同或不同地选自为C1~C10烷基或C1~C10链烯基中;Wherein, Y is -N(R 5 ) 2 or -OR 5 , and R 5 , R 6 and R 7 are identically or differently selected from C1~C10 alkyl or C1~C10 alkenyl; 化合物VI经还原、环合、氯代得到式A’化合物;或者其中中间体化合物VII、化合物A不经分离直接反应得到式A’化合物;其反应式为:Compound VI is reduced, cyclized, and chlorinated to obtain the compound of formula A'; or wherein the intermediate compound VII and compound A are directly reacted without separation to obtain the compound of formula A'; the reaction formula is: 或者 or (2)化合物I在还原条件下得到化合物VIII,化合物VIII与化合物E进行缩合反应得到化合物VII和/或化合物IX,化合物VII和/或化合物IX经环合、氯代得到式A’所示化合物;或者中间体化合物VII/化合物IX和化合物A不经分离直接制备式A’所示化合物;其反应式为:(2) Compound I obtains compound VIII under reducing conditions, compound VIII and compound E undergo condensation reaction to obtain compound VII and/or compound IX, compound VII and/or compound IX undergoes cyclization and chlorination to obtain the compound shown in formula A' or intermediate compound VII/compound IX and compound A directly prepare the compound shown in formula A' without separation; its reaction formula is: or 8.根据权利要求6或7所述的式I所示的6-硝基苯乙酮类化合物的用途,其特征在于,还原条件为:在氢化催化剂存在条件下,通入氢气进行反应,氢化催化剂为钯碳、活性镍或PtO2;或者还原条件为:加入还原剂,还原剂是铁粉、锌粉或氯化亚锡。8. according to the purposes of the 6-nitroacetophenone compounds shown in the formula I described in claim 6 or 7, it is characterized in that, reduction condition is: under the condition that hydrogenation catalyst exists, feed hydrogen to react, hydrogenation The catalyst is palladium carbon, active nickel or PtO 2 ; or the reduction condition is: adding a reducing agent, which is iron powder, zinc powder or stannous chloride. 9.根据权利要求8所述的式I所示的6-硝基苯乙酮类化合物的用途,其特征在于,还原条件为:在氢化催化剂存在条件下,通入氢气进行反应,氢化催化剂为钯碳,所用溶剂为醋酸;或者还原条件为:加入还原剂,还原剂是铁粉或锌粉,进一步加入氯化钙或冰乙酸,所用溶剂为醇或醇-水混合溶剂。9. the purposes of the 6-nitroacetophenone compounds shown in formula I according to claim 8, it is characterized in that, reduction condition is: under hydrogenation catalyst existence condition, pass into hydrogen and react, hydrogenation catalyst is Palladium carbon, the solvent used is acetic acid; or the reduction condition is: add a reducing agent, the reducing agent is iron powder or zinc powder, and further add calcium chloride or glacial acetic acid, and the solvent used is alcohol or an alcohol-water mixed solvent. 10.根据权利要求6所述的式I所示的6-硝基苯乙酮类化合物在制备式A所示化合物中的用途,其特征在于,X为氰基的式A所示化合物,按如下方法制备:10. The purposes of the 6-nitroacetophenone compound shown in the formula I according to claim 6 in the compound shown in the preparation formula A, it is characterized in that, X is the compound shown in the formula A of cyano group, according to Prepared as follows: (1)(1) 或者 or (2)(2) or 其中,其中R1、R2和Z的定义与权利要求1相同;Y的定义与权利要求6相同。Wherein, the definitions of R 1 , R 2 and Z are the same as in claim 1; the definition of Y is the same as in claim 6. 11.根据权利要求6或7或10所述的式I所示的6-硝基苯乙酮类化合物的用途,其特征在于,其制备方法中所述的化合物E为N,N-二甲酰胺二甲缩醛、原甲酸三甲酯或原甲酸三乙酯,与E的反应条件是在常温或加热条件下直接将底物与E混合进行反应。11. according to the purposes of the 6-nitroacetophenone compounds shown in formula I described in claim 6 or 7 or 10, it is characterized in that, the compound E described in its preparation method is N,N-dimethyl The reaction condition of amide dimethyl acetal, trimethyl orthoformate or triethyl orthoformate with E is to directly mix the substrate and E under normal temperature or heating conditions for reaction. 12.如下式II所示化合物:12. The compound shown in the following formula II: 其中,R1、R2和Z的定义与权利要求1-2中任意一项权利要求中的R1、R2和Z定义相同。Wherein, the definitions of R 1 , R 2 and Z are the same as the definitions of R 1 , R 2 and Z in any one of claims 1-2. 13.如下式IV所示化合物:13. The compound shown in the following formula IV: 其中,R1、R2和Z的定义与权利要求1-2中任意一项权利要求中的R1、R2和Z定义相同。Wherein, the definitions of R 1 , R 2 and Z are the same as the definitions of R 1 , R 2 and Z in any one of claims 1-2. 14.如下式V所示化合物:14. The compound shown in the following formula V: 其中R1、R2、X和Z的定义与权利要求1-2中任意一项权利要求中的R1、R2、X和Z定义相同;R4的定义与权利要求4中定义相同。The definition of R 1 , R 2 , X and Z is the same as that of R 1 , R 2 , X and Z in any one of claims 1-2; the definition of R 4 is the same as that in claim 4.
CN200980129186.8A 2008-06-13 2009-06-12 6-nitroacetophenone compound, its preparation method and use Expired - Fee Related CN102105433B (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN200980129186.8A CN102105433B (en) 2008-06-13 2009-06-12 6-nitroacetophenone compound, its preparation method and use

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
CNA200810038964XA CN101602687A (en) 2008-06-13 2008-06-13 6-nitroacetophenone compound, its preparation method and use
CN200810038964.X 2008-06-13
CN200980129186.8A CN102105433B (en) 2008-06-13 2009-06-12 6-nitroacetophenone compound, its preparation method and use
PCT/CN2009/000653 WO2009149622A1 (en) 2008-06-13 2009-06-12 6-nitro acetophenone compounds, preparation methods and uses thereof

Publications (2)

Publication Number Publication Date
CN102105433A CN102105433A (en) 2011-06-22
CN102105433B true CN102105433B (en) 2014-09-10

Family

ID=41416356

Family Applications (2)

Application Number Title Priority Date Filing Date
CNA200810038964XA Pending CN101602687A (en) 2008-06-13 2008-06-13 6-nitroacetophenone compound, its preparation method and use
CN200980129186.8A Expired - Fee Related CN102105433B (en) 2008-06-13 2009-06-12 6-nitroacetophenone compound, its preparation method and use

Family Applications Before (1)

Application Number Title Priority Date Filing Date
CNA200810038964XA Pending CN101602687A (en) 2008-06-13 2008-06-13 6-nitroacetophenone compound, its preparation method and use

Country Status (2)

Country Link
CN (2) CN101602687A (en)
WO (1) WO2009149622A1 (en)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN105693524A (en) * 2014-11-28 2016-06-22 浙江省化工研究院有限公司 A preparing method of nitro compounds
KR102622104B1 (en) * 2015-06-30 2024-01-09 (주)아모레퍼시픽 Preparation method of benzoic acid amide compounds
CN105461565B (en) * 2015-11-17 2017-12-29 阜宁县安勤化学有限公司 A kind of method for producing nitro-acetophenone
CN109553533A (en) * 2017-09-27 2019-04-02 江苏瑞科医药科技有限公司 Flurbiprofen intermediate and preparation method thereof
CN115819243B (en) * 2022-10-19 2024-03-29 浙江理工大学 Preparation method of 4-hydroxy-3-nitroacetophenone

Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1993007137A1 (en) * 1991-10-11 1993-04-15 Smithkline Beecham Plc Pyridinol derivatives as medicaments
US5276027A (en) * 1991-10-23 1994-01-04 Merck Patent Gesellschaft Mit Beschrankter Haftung Thiadiazinones
CN1176101A (en) * 1996-07-19 1998-03-18 弗·哈夫曼-拉罗切有限公司 N -(4 -aryl -thiazol -2 -yl) -sulphonamide derivatives and their use
CN1665787A (en) * 2002-04-30 2005-09-07 惠氏控股公司 Process for the preparation of 7-substituted-3-quinoline and 3-quinol-4-one carbonitriles
CN101012225A (en) * 2007-02-01 2007-08-08 中国药科大学 3-Cyanoquinoline derivative, preparation method and medical use thereof

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3478084A (en) * 1965-12-22 1969-11-11 Merck & Co Inc Lower alkyl alpha-carboalkoxy-beta-(3,4-disubstituted anilino) acrylates
US3485845A (en) * 1966-05-13 1969-12-23 May & Baker Ltd Methyl and ethyl 6- and 7-substituted 4-hydroxy-quinoline-3-carboxylates useful as coccidiostats
US3657319A (en) * 1970-05-05 1972-04-18 Smith Kline French Lab Alpha-aminoalkyl-4-hydroxy-3-carboalkoxyaminobenzyl alcohols
US4024281A (en) * 1972-05-26 1977-05-17 Smithkline Corporation N,N-bis[2-(3-substituted-4-hydroxyphenyl)-ethyl or -2-hydroxyethyl]-polymethylenediamines
US3943173A (en) * 1972-11-22 1976-03-09 Smithkline Corporation 3-Alkylamino- alpha-aminomethyl-4-hydroxybenzyl alcohols
IL65809A (en) * 1981-06-01 1986-07-31 Merrell Toraude & Co Aminoacid derivatives,their preparation and pharmaceutical compositions containing them
US5134138A (en) * 1989-07-18 1992-07-28 Shionogi & Co., Ltd. Phenacylpyridiniothiocephalosporins
AU644008B2 (en) * 1990-08-10 1993-12-02 Sumitomo Pharmaceuticals Company, Limited Beta-lactam compounds, and their production and use
DE60128211T2 (en) * 2000-03-31 2008-01-10 Ortho-Mcneil Pharmaceutical, Inc. PHENYL-SUBSTITUTED IMIDAZOPYRIDINE
JP2003313176A (en) * 2002-04-24 2003-11-06 Sankyo Co Ltd Aminoazole derivative
JP2007197369A (en) * 2006-01-26 2007-08-09 Sankyo Co Ltd Benzothiadiazine derivative

Patent Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1993007137A1 (en) * 1991-10-11 1993-04-15 Smithkline Beecham Plc Pyridinol derivatives as medicaments
US5276027A (en) * 1991-10-23 1994-01-04 Merck Patent Gesellschaft Mit Beschrankter Haftung Thiadiazinones
CN1176101A (en) * 1996-07-19 1998-03-18 弗·哈夫曼-拉罗切有限公司 N -(4 -aryl -thiazol -2 -yl) -sulphonamide derivatives and their use
CN1665787A (en) * 2002-04-30 2005-09-07 惠氏控股公司 Process for the preparation of 7-substituted-3-quinoline and 3-quinol-4-one carbonitriles
CN101012225A (en) * 2007-02-01 2007-08-08 中国药科大学 3-Cyanoquinoline derivative, preparation method and medical use thereof

Also Published As

Publication number Publication date
CN101602687A (en) 2009-12-16
WO2009149622A1 (en) 2009-12-17
CN102105433A (en) 2011-06-22

Similar Documents

Publication Publication Date Title
CN102105433B (en) 6-nitroacetophenone compound, its preparation method and use
CN102731395B (en) Intermediate compound of antitumor drug neratinib and its preparation method and use
CN101993407A (en) Indoline compound for preparing silodosin and preparation method thereof
CN101402610A (en) Synthesis method of 4-(3-chlorine-4-fluorobenzene amino)-7-methoxy-6-[3-(4-morpholinyl)-propoxy] quinoline
CN104030981A (en) Preparation method and intermediate of Ivacaftor
CN103570633B (en) The preparation method of Gefitinib
CN105418483A (en) Preparation method of crystalline nintedanib esylate
CN103936631B (en) A kind of Biphenyl carbamide compound containing oximido and its preparation method and application
CN107162973B (en) Intramolecular Decarboxylation Coupling to Construct C-N Bonds to Synthesize Acridone Derivatives
CN110498771A (en) A kind of method for preparing the intermediate of Elagoli
CN109988108A (en) A kind of rich preparation method for Buddhist nun of card
CN102123981B (en) Preparation method and intermediates of 6-substituted amino-3-cyanoquinoline compounds
CN104230885B (en) The preparation method of imatinib
Kumar et al. A simple and highly efficient process for synthesis of Gefitinib and its intermediate
CN104592222B (en) The preparation method of antiplatelet drug AZD6482
CN105837522A (en) Preparation method of 1,5-benzodiazepine-one derivative
CN115197261A (en) Synthesis method of oxadiazabenzboron derivative
CN114716378A (en) A kind of synthetic method of 1,3,4-tri-substituted-5-cyanopyrazole derivatives
CN103172564B (en) The preparation method of Aripiprazole
CN107573336A (en) Benzheterocycle carboxamide pyridine ketone derivatives and its production and use
MX2008015050A (en) Process for synthesizing piperazine-piperidine compounds.
CN101538252B (en) Novel preparation method and intermediate for aripiprazole
JP2022546126A (en) Benzimidazole-substituted phenyl-n-butanamide compound and method for producing same
CN103992308A (en) Method for preparing sunitinib
CN114621109B (en) Synthesis method of apatamide and intermediate thereof

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
C14 Grant of patent or utility model
GR01 Patent grant
CF01 Termination of patent right due to non-payment of annual fee

Granted publication date: 20140910

Termination date: 20170612

CF01 Termination of patent right due to non-payment of annual fee